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Transcription factors in the AP-1 family (which includes c-Jun) play critical roles 
in basal CNS function and in patho-physiology associated with neuronal disorders. 
Nitric oxide (NO) overproduction is partly responsible for neuronal cell death in 
various types of neurodegeneration. An involvement of AP-1 in NO-induced neuronal 
apoptosis has not been explored. I found that in human SH-Sy5y neuroblastoma cells, 
NO induced apoptosis following JNK activation and phosphorylation of c-Jun almost 
exclusively on Ser-63. NO-induced apoptosis was inhibited in cells stably transformed 
with dominant-negative c-Jun in which Ser-63 is mutated to alanine (S63A), but not in 
cells transformed with dominant-negative c-Jun (S73A). Ser-63 of c-Jun (but not Ser-
73) was required for NO-induced, c-Jun-dependent transcriptional activity. NO-
induced apoptosis and Ser-63 phosphorylation of c-Jun were inhibited in SH-Sy5y 
cells transformed with dominant-negative jnk. I conclude that NO-inducible apoptosis 
is mediated by JNK-dependent Ser-63 phosphorylation of c-Jun in neuroblastoma cells. 
Opposite observations were made using another dominant negative form of c-
Jun, TAM67 (transactivation domain deletion mutant of c-Jun). Cells stably over-
expressing TAM67 were sensitized to NO, suggesting a protective role of c-Jun/AP-1. 
Microarray analysis identified secretogranin II (SgII) as an NO-inducible, c-Jun-
regulated protective gene. NO stimulated reporter gene expression from a short sgII 
promoter region harboring its own intact CRE element (but not a mutated CRE 
element) in transiently transfected SH-Sy5y neuroblastoma cells. Basal and NO-
inducible expression of the sgII gene, as well as basal SgII protein synthesis were 
severely compromised in TAM67 stable cells, which were more sensitive to NO-
induced apoptosis and failed to undergo nerve growth factor (NGF)-dependent 
 xii
neuronal differentiation. When sgII mRNA was stably transformed into TAM67 cells, 
neuronal differentiation and resistance to NO were restored. RNA interference-
mediated sgII knockdown rendered SH-Sy5y cells sensitive to NO-induced apoptosis 
and abolished neuronal differentiation. Thus, SgII synthesis largely depends on c-
Jun/AP-1-mediated transcription. Importantly, SgII represents a new class of proteins 
that counteracts NO toxicity and mediates NGF-induced neuronal differentiation of 
neuroblastoma cells. 
The opposing effects of the dominant-negative c-Jun (TAM-67) and S63A can 
be explained: TAM-67 efficiently inhibits constitutive AP-1-mediated transcription in 
SH-Sy5y cells and thus blocks SgII-mediated cell survival. The synthesis of SgII does 
not require Ser-63 phosphorylation of c-Jun, because it occurred in the absence of NO 
stimulation. In contrast to TAM-67 cells, SgII proteins were still synthesized at normal 
levels in NO-resistant S63A cells, indicating the c-Jun/AP-1-dependent SgII survival 
pathway is intact in these cells. The S63A construct blocked the pro-apoptotic JNK-c-
Jun pathway without affecting the synthesis of neuroprotective SgII, so the cells were 
resistant to apoptosis compared to SH-Sy5y cells and TAM-67 cells. The basal activity 
of c-Jun/AP-1 factor(s) (independent of c-Jun phosphorylation on Ser-63) is able to 
counteract relatively low levels of NO - in part through the constitutive expression of 
neuroprotective SgII. In contrast, a threshold toxic concentration of NO will lead to c-
Jun phosphorylation on Ser-63 by JNK that triggers apoptosis via yet to be discovered 
c-Jun targets.  
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CHAPTER 1      INTRODUCTION 
 
This chapter will begin with an overview of programmed cell death (apoptosis), 
followed by two mini reviews on nitric oxide and AP-1, respectively. Emphasis will be 
placed on the current understanding of nitric oxide chemistry and its biological 
significance.  In the mini review of AP-1, the regulation of AP-1 activity and the 
overall roles of AP-1 are discussed; and molecular mechanisms mediating AP-1 
functions in different processes will be highlighted. Lastly, the rationale of the thesis 
will be discussed.   
 
1.1 Programmed cell death 
Programmed cell death (PCD) is an evolutionary conserved process that is 
important for multicellular organisms to delete unwanted cells during development and 
homeostasis (Ellis et al., 1991; Jacobson et al., 1997). Two major types PCD were 
characterized so far: apoptosis (type I) and autophagic cell death (type II).  
Morphologically, cells undergoing apoptosis exhibit membrane blebbing, 
cytoplasmic shrinkage and chromatin condensation. Apoptotic cells are degraded into 
membrane-bound fragments called apoptotic bodies, which are rapidly engulfed by the 
neighboring cells or professional macrophages (Kerr et al., 1972). The process of 
apoptosis is neat and quick with no induction of inflammation, which may be one 
reason why it was neglected for so long. In contrast, necrosis, a pathological form of 
cell death resulting from acute cellular injury, is characterized by cell swelling and 
lysis, release of cytoplasmic contents, and the induction of an inflammatory response 
(Wyllie et al., 1980). Biochemically, apoptotic cells exhibit externalization of 
phosphatidylserine (PS), reduction of mitochondrial transmembrane potential, release 
of cytochrome c from mitochondria into the cytoplasm, degradation of chromosomal 
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DNA into oligonucleosomal fragments and selective cleavage of a subset of 
intracellular proteins (see reviews by Fadok et al., 1998; Green and Reed, 1998; Stroh 
and Schulze-Osthoff, 1998).  
The mechanisms of how apoptosis is initiated and executed remained unclear 
until the molecular identification of the key components of this intracellular suicide 
program. The typical apoptotic process can be divided into three functional distinct 
phases: an induction phase, during which the cell is challenged by changes in the 
cellular environment and the nature of which depends on the specific death-inducing 
signals; an effector phase, during which the central executioners are activated and the 
cells become committed to die; and a degradation phase, during which cells acquire the 
biochemical and morphological features of end-stage apoptosis (Green and Kroemer, 
1998; Wilson, 1998). Genetic studies of the nematode worm Caenorhabditis elegans 
have provided powerful clues to the identity of the molecular species important in 
controlling apoptosis (Wilson, 1998). These studies identified three C. elegans death 
genes, named egl-1, ced-3 and ced-4 (egl, egg-laying abnormal; ced, cell death 
abnormal), that were required for developmental apoptosis (Conradt and Horvitz, 1998; 
Ellis and Horvitz, 1986), and a fourth gene, ced-9, that inhibits apoptosis (Hengartner 
et al., 1992). The molecular cloning of egl-1, ced-3, ced-4 and ced-9 led to the finding 
that these core components of the cell death machinery in C. elegans have counterparts 
in other organisms including mammals (Fig 1.1). The ced-3 gene encodes a protein 
similar to the cysteine protease interleukin-1β-converting enzyme (ICE) (Yuan et al., 
1993), a prototype of a family of proteases (collectively called caspases). The ced-4 
gene encodes a protein similar to a mammalian protein celled Apaf-1 (Apaf, apoptotic 
protease-activating factor) (Zou et al., 1997). The ced-9 gene encodes a protein similar 
to the mammalian protein Bcl-2 (Bcl, B cell lymphoma) (Hengartner and Horvitz, 
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1994), a prototype of a family of both antiapoptotic and proapoptotic proteins. Lastly, 
the egl-1 gene encodes a protein similar to the mammalian “BH3-only” (BH, Bcl-2 
homology domain) proteins, a subfamily of Bcl-2 family. The fact that these key cell 
death components in C. elegans have mammalian counterparts indicates that the 
molecular mechanism of PCD is evolutionarily conserved (Steller, 1995). 
 
EGL-1 CED-9 CED-4 CED-3
Bid/Bad Bcl-2/Bcl-xL Apaf-1 Caspases
(BH3-only subfamily) (Bcl-2 subfamily)
 
Fig 1.1 Core cell death components in C. elegans and their counterparts in mammals. 
 
Among the aforementioned three major players in apoptosis: caspases, Bcl-2 
family proteins and Apaf-1 adaptor proteins, caspases are the central executioners 
(Hengartner, 2000). Most of the morphological changes of apoptotic cells are probably 
caused by caspase activation and consequent cleavage of their substrates that fulfill 
important cellular functions (Hengartner, 2000; Raff, 1998). The other two players 
function through directly or indirectly regulating caspase activity. There are two 
general pathways leading to caspase activation and cell death. Death signals 
originating from the death receptors (TNFR or Fas/CD95/Apo1) or resulting in 
mitochondrial dysfunction trigger the activation of caspase-8 or caspase-9 respectively 
through their individual adaptor proteins FADD/TRADD or Apaf-1. These activated 
initiator caspases in turn activate the downstream executioner caspases 3, 6 or 7 which 
further cleave a variety of cellular proteins leading to the dismantling of the nucleus, 
DNA degradation, cytoskeleton breakdown, and detachment of the cells from their 
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neighbours. The cross talk between the two pathways is mediated by Bid, which can 
translocate to mitochondria upon cleavage by caspase-8 and activate the mitochondria-
mediated cell death pathway (Adams and Cory, 1998; Colussi and Kumar, 1999; Slee 
et al., 1999). A schematic stepwise representation for caspase activation during 













Fig 1.2 Two classical pathways leading to caspase activation.  Death receptor engagement causes the 
activation of initiator caspase-8. Mitochondrial damage results in cyto C release and intiator caspase-9 





In contrast to the condensation prominent apoptosis, the autophagic cell death is 
autophagy prominent characterized by formation of autophagic vacuoles, degradation 
of cytoplasmic components including Golgi apparatus, polyribosomes, and 
endoplasmic reticulum due to activation of proteases in lysosomes. Intermediate and 
microfilaments are largely preserved, probably because cytoskeleton structure is 
important for autophagocytosis.  Cell death of this type is independent of caspases and 
DNA fragmentation was rarely seen. In many tissues, autophagy is a means of 
reducing cell mass prior to apoptosis. It can also be used in situation in which 
conventional apoptosis pathways are blocked or limited (Bursch, 2001; Lockshin and 
Zakeri, 2004). 
Although distinct biochemical and molecular features have been be assigned to 
these two different types of PCD, they are not mutually exclusive phenomena (Bursch, 
2001). Apoptosis can start with autophagy and autophagy can end with apoptosis. 
Furthermore, blockage of caspases can result in a cell to default to autophagic cell 
death from apoptosis. 
The occurrence of PCD may not be an essential event in the C. elegans lifespan 
since the worm appears normal in size and viability with total elimination of apoptosis 
(Raff, 1998). However, PCD plays a vital role in more complex organisms, enabling 
the normal development of the organisms (Jacobson et al., 1997), maintaining tissue 
homeostasis in the adults as well as keeping the immune system effective (Raff, 1998). 
Deregulation of PCD has been associated with various human diseases (Thompson, 
1995). For example, there are many disorders where cells die prematurely: heart cells 
die during a heart attack and brain cells die during a stroke (Raff, 1998). In these acute 
conditions, many cells die by necrosis. But some of the less badly damaged cells die by 
apoptosis. Also, in neurodegenerative diseases, such as Alzheimer’s, Parkinson’s or 
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Huntington’s, nerve cell loss occurs slowly. It has been established that caspase 
activity is involved in the processes leading to the pathology of these diseases 
(Pettmann and Henderson, 1998; Yuan and Yankner, 1999). Insufficient cell death is 
linked to the occurrence of cancer and autoimmune diseases. In the former case, the 
malignant cells with genetic mutations escape the cellular guardian systems and divide, 
causing tumorigenesis and hence malignancy. In the latter case, deficient cell death in 
the immune system results in prolonged or overactive immune responses. A further 
understanding of the molecular genetic mechanisms underlying those diseases is 
expected to provide clues for more specific therapies. 
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1.2 Nitric oxide in health and disease 
 1.2.1 Formation and chemistry of nitric oxide 
Nitric oxide (NO) is catalytically produced by 3 different NO-synthase (NOS) 
isoforms in a reaction scheme (Brune et al., 1998; Stuehr, 1999), involving the five 
electron oxidation of the terminal guanido nitrogen of the amino acid L-arginine to 
form NO and L-citrulline (Fig 1.3). In addition, NO can also be generated non-
enzymatically in tissues by either direct disproportionation or reduction of nitrite to 
NO under the acidic and highly reduced conditions which occur in disease states, such 






Fig 1.3 Enzyme-catalyzed formation of NO from L-Arginine. Hydroxylation of L-Arginine generates 
N-hydroxy-L-Arg (NOHarg) as an intermediate. The second step converts NOHarg to NO and citrulline 
(Stuehr, 1999).  
 
 
The low output NO (also known as signal molecule NO) generation by 
constitutively expressed NOS (cNOS) can last for only short periods (seconds to 
minutes) and mediates homeostatic processes such as neurotransmission and blood 
pressure regulation (Nathan and Xie, 1994a). cNOS is further classified as eNOS or 
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nNOS according to the characteristic cells expressing them (Nathan and Xie, 1994a; 
Nathan and Xie, 1994b). Elevated intracellular Ca2+ concentrations seem important for 
the full enzyme activity of cNOS.  For example, in the CNS, acute neuronal damage is 
coupled to glutamate release into the extracellular matrix, membrane-spanning 
NMDAR activation and consequent Ca2+ influx into the cellular compartment, which 
greatly enhances the eNOS activity and causes massive NO generation and 
cytotoxicity. The high output NO (also known as killer molecule NO) is synthesized 
predominantly by inducible NOS (iNOS) (Nathan and Xie, 1994a) and can last for 
long periods (hours to days). Although the iNOS activity is independent of Ca2+, its 
expression is highly inducible upon stimulation of cells by microbes and microbial 
products, some tumor cells and numerous cytokines (Nathan and Xie, 1994a; Nathan 
and Xie, 1994b). NO generation in such scenari often correlates with non-specific host 
defense via infection or inflammation. Besides, other factors like intracellular 
localization of NOS, palmitoylation and phosphorylation of NOS are believed to 
modulate NOS enzyme activity (Nathan and Xie, 1994a; Nathan and Xie, 1994b). 
Recently, mitochondrial localization of NOS has also been proposed (Ghafourifar and 
Richter, 1997; Giulivi et al., 1998; Kanai et al., 2001), the importance of which will be 
discussed in section 1.2.2. In the laboratory, to mimic NO generation irrespective of 
NOS involvement, NO releasing compounds (also called “NO donors”) are valuable 
tools (Butler et al., 1995). NO donors preserve NO in their molecular structure and 
evoke biological activities upon decomposition (Brune et al., 1998). Examples are 
organic nitrate such as sodium nitroprusside (SNP), 3-morpholino-sydnonimine (SIN-1) 
and diethylenetriamine nitric oxide adduct (DETA-NO). Once generated, NO is highly 
diffusible and easily passes membranes and sets up trans-cellular or local concentration 
gradients within cells and subcellular compartments like mitochondria (Boyd and 
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Cadenas, 2002). The steady-state level of NO will be determined by the nature of the 
local microenviroment (discussed below).  
Although NO is a radical, it lacks the reactivity normally inherent to other 
radicals. This makes NO relatively innocuous to cells, but some key chemical reactions 
can lead to the production of more reactive species, potentially more toxic than NO 
itself. Biologically significant NO redox and additive reactions include those with 
(di)oxygen and its various redox forms and with transition metals (Boyd and Cadenas, 
2002; Cooper, 1999; Torres and Wilson, 1999) as summarized in Fig 1.4.  
Oxidation of NO by O2 alone can lead to various nitrogen oxide species 
(collectively called NOX) existing simultaneously in aqueous solution including 
NO, ·OONO, NO2, (NO)2, N2O3, N2O4, NO2- and NO3- (irrespective of the redox 
reactions with other biochemical components in the microenviroment) (Boyd and 
Cadenas, 2002). In addition, NO can undergo radical-radical interactions with other 
oxygen- and nitrogen-centered radicals. The former includes its reaction with O2·- to 
yield peroxynitrite (ONOO-); with the hydroxyl radical (HO·) to yield HNO2; and with 
the peroxyl radical (ROO·) to yield ROONO. The latter includes its reaction with NO2 
to yield N2O3; with ONOO- to yield nitrosating species (Boyd and Cadenas, 2002). So 
the nature of NOX can be significantly altered by the availability of other oxyradicals 
which are normally ubiquitous and highly diffusible in the cytosol. Alternatively, the 
fate of NO can be shifted if it is produced by NOS in close proximity to the sources of 
O2·- or H2O2 (such as NADPH oxidase) (Fig 1.4).  
Of the entire NO related species, NO-, NO+ and ONOO- are of great biological 








Fig 1.4 NO chemistry in the cellular environments (Boyd and Cadenas, 2002). Endogenous NO is 
synthesized by different NOS enzymes. Once generated, NO freely diffuses creating concentrations 
across the subcellular compartments. Redox or additive reaction with constituents of the local 
microenviroment converts NO to a number of NOx species and establishes the steady-state 
concentrations of each. The generation of NO+ carriers (nitrosating species) is likely under 
physiological conditions, leading to the formation of GSNO and RSNO species, which participate in 
trans-nitrosation reactions. The ratio GSH/GSSG, a key index of the cellular redox potential, can be 
shifted in opposite directions by either NO+ carriers or NO-, in turn establishing the importance of the 
nature of the NOx species to the redox state. 
 
 
NO+, the oxidized form of NO (by electron loss), has the potential to regulate cell 
signaling pathways due to its ability to nitrosate (Gaston, 1999; Hughes, 1999). 
Nitrosation is a process in which the NO+ group is transferred (usually from a carrier 
compound such as N2O3 and metal-nitrosyl complexes) to a nucleophilic center, often 
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to a sulfur or nitrogen lone pair of electrons. These reactions create a series of new 
NO+ donors like N-nitrosamines and S-nitrosothiols, which can then participate in 
further trans-nitrosation reactions. S-nitrosothiol formation, through the S-nitrosation 
of either free or protein thiols, has real biological significance (it will be discussed in 
section 1.2.3). S-nitrosothiols act as a bioactive pool serving as a source and sink of 
NO, buffering the free NO. S-nitrosothiols are relatively stable, prolonging the half-life 
of NO and protecting against the generation of more toxic NOX species (Boyd and 
Cadenas, 2002). Furthermore S-nitrosation of proteins, occuring favorably under 
physiological conditions, is reversible and capable of trans-nitrosation reactions: two 
criteria that point to S-nitrosation as a potential cellular regulatory mechanism (Fig 
1.4). In this regard, reduced glutathione (GSH), the most abundant cellular thiol, is 
likely to be the major intracellular mediator of NO storage and transport, forming S-
nitrosoglutathione (GSNO). It is noteworthy that S-nitrosothiol formation is considered 
the typical redox-based NO-signaling mechanism, which is cGMP-independent and 
has previously been considered to mainly account for the cytostatic, cytotoxic or 
protective NO effects (Lipton, 1999).  
NO-, the reduced form of NO (by electron gain), is a short-lived species in 
solution, decomposing via dimerization and dehydration to give nitrous oxide. NO- 
reacts with a variety of targets such as iron-sulfur center of cytochrome d, cysteine 
residue of ferrocytochrome c and more importantly, it reacts with oxygen to generate 
peroxynitrite (Hughes, 1999). That is at least partly responsible for its toxic effects. 
ONOO- is a highly reactive product of NO. ONOO- can react with tyrosine 
residues in many target proteins via nitration and also it involves in the process of 
hydroxylation. Furthermore, peroxynitrite is a strong oxidizing agent and readily 
oxidizes most components in mitochondria, causing oxidation and cross-linking of 
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proteins, irreversible inhibition of most of the mitochondrial complexes, oxidation of 
non-protein thiols, membrane lipids and thus disrupt the mitochondrial membrane 
(Brown, 1999; Hughes, 1999; Radi et al., 2002). 
NO also reacts with transition metal such as iron or copper and regulate the cell 
signaling pathways. NO is capable of binding to both the ferric (FeIII) and ferrous (FeII) 
oxidation states of iron (Boyd and Cadenas, 2002; Cooper, 1999). The reaction with 
FeIII involves a catalytic process called reductive nitrosation: reduction of metal by NO 
and formation of bound NO+, the nitrosonium cation. Reduction of non-heme iron has 
also been observed, including iron-sulfur centers in proteins such as components of the 
mitochondrial respiratory chain and other mitochondrial enzymes. NO also shows high 
affinity to FeII, forming a stable nitrosyl complex in competion with O2. NO in such a 
process is reduced to the nitroxyl anion (NO-), which can oxidize sulfhydryl (thiol) 
groups. Oxymyoglobin and hemoglobin are important NO scavengers in this regard 
(Fukuto, 1995). NO also can react with copper (Cu2+) proteins (Torres and Wilson, 
1999), acting as a fast one-electron reductant at Cu2+, such as haemocyanin, tyrosinase 
and cytochrome c oxidase.  
Based on the NO chemistry discussed above, formation of NO-derived species 
shows high dependence on pH, O2 tension, redox state and the transition metal content 
of the local environment (Boyd and Cadenas, 2002). The steady-state levels of oxygen- 
and nitrogen-centered radicals are a key contributor to the oxidative potential, whereas 
intracellular GSH is a major determinant of the reductive potential (Fig 1.4). The net 
balance between the oxidative and reductive potentials within a cell determines the 
cellular redox state and perhaps the fate of the cell or organism. 
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1.2.2 Influence of nitric oxide on important cellular organelles 
 
The mitochondria is a primary intracellular target of NO (Radi et al., 2002) for 
the following reasons: (1) the diffusible nature of NO through biomembrane as well as 
local generation of NO in mitochondria; (2) the presence of large amounts of 
metalloproteins such as cytochrome c oxidase, which rapidly react with NO; (3) the 
intramitochondrial thiol pool, which serves as a primary reactant for the actions of 
oxidized forms of NO such as N2O3 that lead to S-nitrosation; and (4) the 
intramitochondrial formation of O2.- (Boyd and Cadenas, 2002) that results in rapid NO 
consumption and formation of the strong oxidant and nitrating species peroxynitrite 
anion (ONOO-). 
NO impairs electron flux through the respiratory chain through the inhibition of 
multiple sites (Boyd and Cadenas, 2002; Brown, 1999; Radi et al., 2002). At low 
physiological concentrations (10 nM – 1 µM), NO inhibits cytochrome c oxidase 
(Complex IV, the terminal complex of the mitochondrial respiratory chain, responsible 
for about 90% of oxygen consumption and for virtually all energy production in cells.) 
and the ubiquinone-bc1 segment (complex III) of the respiratory chain. The inhibition 
of cytochrome c oxidase is reversible and involves oxidation of the heme group (O2 
binding domain) of cytochrome aa3 and possibly CuB+ through the competitive binding 
with O2. The interactions of NO with cytochrome c oxidase, precluding the reduction 
of molecular oxygen, lead to a larger concentration of reduced components of the 
electron transport chain such as O2.-, NO- and NO2- (Radi et al., 2002). The inhibition 
of the bc1 segment is partially reversible and leads to the auto-oxidation of 
ubisemiquinone with the subsequent generation of O2.- 
 and thus H2O2. At higher 
concentrations (>1 µM), NO can directly oxidize ubiquinol, promoting 
ubisemiquinone auto-oxidation. The fate of O2.- generated in these reactions is highly 
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dependent on the local NO concentrations: at a low [NO]ss superoxide dismutation to 
H2O2 is favored; and at a high [NO]ss the conversion to ONOO- is favored. 
Peroxynitrite itself can oxidize ubiquinol, amplifying generation of O2·- as well as 
itself potentially. The NO-induced production of O2·- and ONOO- results in the 
selective and persistent inhibition of NADH:ubiquinone reductase (Complex I) and 
Complex II activity. Peroxynitrite also causes irreversible damage to mitochondrial 
ATP synthase (Complex V), presumably through the oxidation of critical thiols, and 
promotes the permeability transition, cytochrome c release and apoptosis. The 






Fig 1.5 The targeting sites of NO and ONOO- on the mitochondria complexes (Brown, 1999). 
Electron pathways are represented by light arrows, and inhibitions are depicted as thunderbolts. 
 
 
Besides the components of respiratory chain, NO and its derivatives also readily 
react with mitochondrial matrix proteins including aconitase, MnSOD and creatine 
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kinase (Radi et al., 2002). NO influence on cell energy metabolism is partially due to 
the NO-dependent disruption of the Fe-S cluster present in the active site of 
mitochondrial aconitase since it participates in the Krebs cycle. NO can bind to the 
iron center and reversibly inhibit aconitase at low rates while ONOO- can rapidly 
oxidize and disrupt the cluster. MnSOD, the critical enzyme for detoxification of 
intramitochondrial O2·-, is inactivated by ONOO--mediated nitration of critical Tyr-34. 
In turn, inactivation of MnSOD promotes a vicious cycle resulting from an enhanced 
mitochondrial steady-state concentration of O2·- which would favor further ONOO-   
formation and mitochondrial oxidative damage. Mitochondrial creatine kinase, the 
enzyme for synthesis and degradation of creatine-phosphate, is inactivated by ONOO-
through oxidation of critical protein thiols. Inactivation of creatine kinase may affect 
mitochondrial energy metabolism and indirectly promote calcium accumulation in the 
cytosol due to the alterations of the ATP-dependent calcium transport to the 
mitochondria. 
NO interactions with cytochrome c oxidase may play two important 
physiological roles (Radi et al., 2002). Firstly, low levels of NO may serve as a 
physiological regulator of tissue respiration: it causes a transient, reversible de-
energization of the mitochondria and help to attenuate the oxygen tension gradient. 
The physiological significance for such a regulation is not completely understood, 
although it has been proven from both exogenously added NO and endogenously 
produced NO on various cell types (Brown, 1999). Since NO competes with oxygen at 
cytochrome c oxidase, some scholars (Brown, 1995) suggest that NO may be a 
physiological regulator of the oxygen sensitivity of respiration in tissues. Secondly, 
NO interactions with cytochrome c oxidase may exert anti-apoptotic actions through 
inhibiting mitochondrial signaling of cell death in the following way: interaction 
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between NO and cytochrome c oxidase results in mitochondrial depolarization, 
inhibition of calcium uptake, blockage of the mitochondrial transition pore (MTP) 
opening and thus hold up the release of pro-apoptotic components such as cytochrome 
c and Diablo/Smac. NOS localization at the inner membrane of mitochondria places a 
source of NO generation adjacent to the respiratory chain (Boyd and Cadenas, 2002), 
which indicates that NO would function to regulate the mitochondrial respiration 
physiologically based on the above discussion.  
In contrast, long-time exposure to NO (most probably through ONOO-) can lead 
to the irreversible inhibition of mitochondrial respiration chain and persistent blockage 
of ATP synthesis (Boyd and Cadenas, 2002; Radi et al., 2002). A transient drop in 
ATP levels appeared to correlate with apoptosis, an energy-dependent process; 
whereas a persistent or complete decline in ATP results in necrosis. In addition, high 
NO fluxes or ONOO- induce the permeability transition and, cytochrome c and Ca2+ 
release from mitochondria and apoptosis. Moreover, release of cytochrome c is 
associated with a burst of mitochondrial O2·- generation that can further alter the 
cellular redox state. The action of NO and peroxynitrite and respective consequences 
for mithchondrial respiration is summarized in Fig 1.6. 
The nucleus is another cellular target for NO. NO has been shown to cause G:C 
→ A:T transitions and to mediate DNA strand breaks (Kroncke et al., 1997). N-
nitrosation of deoxynucleotides and DNA bases deamination predominantly account 
for both cases. Indirect induction of DNA strand breaks, such as via N-nitrosamine 
formation and subsequent alkylation reactions, via activation or inhibition of enzymes 
necessary for nuclear homeostasis, is also possible. Since DNA damage is potentially 
hazardous for the cell, being able to cause mutation and transcription or translation 





Fig 1.6 The actions of NO and ONOO- on mitochondria and the consequences (Brown, 1999). 
 
 
two proteins known to be involved in such repair. p53 is known as a “guardian of the 
genome” and subject to quick upregulation at the protein level upon DNA damage 
(Chernova et al., 1995; Enoch and Norbury, 1995).  It can induce G1 arrest through 
transcriptional activation of p21, an inhibitor of cyclin dependent kinases, and thereby 
block the progression of the cell cycle and permit DNA repair. PARP [poly (ADP-
ribose) polymerase] is a constitutively expressed nuclear protein which is regarded as a 
molecular nick sensor and has a functional role during rejoining of DNA strand breaks 
(Kroncke et al., 1997). After binding to DNA breaks, PARP automodifies itself by 
adding several branched polymer chains of up to 200 ADP-ribose residues, each 
resulting in PARP inhibition and causing its dissociation from the DNA strand breaks. 
The poly (ADP-ribose) polymers are degraded later. PARP is proposed to function in 
the following ways: it may protect DNA strand breaks during early stages of 
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recombination and repair, may induce cell cycle arrest by transiently blocking DNA 
replication or may simply provide an emergency signal. NO treatment has been shown 
to induce p53 expression and to activate PARP in different cells. While p53 expression 
is not detrimental to the cells, activation and consequent poly(ADP-ribosylation) of 
PARP lead to a severe cellular depletion of ATP and NAD+, which may contribute to 
cell death (Fig 1.7). 
 
 
Fig 1.7 Effects of NO on nuclear DNA and response after DNA damage (Kroncke et al., 1997). 
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1.2.3Effects of nitric oxide on some important cellular proteins 
 
NO or its derivatives react with transition metals (iron, copper, zinc and so on) 
and thiol groups, therefore regulating protein functions and cell signaling pathways.  
Reaction of NO with transition metals or metal-containing proteins is of high 
biological significance in NO-mediated cell signal transduction pathways. A classical 
example is the role of NO in cGMP-dependent signaling pathways (Cooper, 1999; 
Denninger and Marletta, 1999). NO binds to the ferrous heme of soluble guanylate 
cyclase and releases the heme-ligating histidine, resulting in a heme Fe2+-NO complex. 
A change in the heme geometry then occurs causing a conformational change of the 
protein to an enzymatically active form. Active guanylate cyclase then results in an 
increase in the second messenger cyclic GMP (cGMP) and activates cGMP-dependent 
protein kinase (PKG) as well as phosphodiesterases, ion channels and other important 
regulatory proteins. This leads to: smooth muscle relaxation and blood pressure; 
platelet aggregation and disaggregation; neurotransmission both peripherally and 
centrally (Denninger and Marletta, 1999). NO also reversibly binds to ferrous heme 
iron of cytochromce c oxidase (discussed in 1.2.2) and inhibits its activity. Also, NO is 
able to bind reversibly to ferric iron, responsible for the inhibition of catalase (an 
enzyme for hydrogen peroxide conversion to water) by NO. Reaction of NO with the 
oxygen adduct of ferrous heme proteins (oxyhaemoglobin) is responsible for the 
metabolism in the vasculature. NO can also interact with iron-sulphur enzymes 
(aconitase, NADH dehydrogenase) (Cooper, 1999). Fig 1.8 summarize the most 
biologically relevant reactions between NO and iron. 
NO- is able to react with iron protein such as myoglobin, oxy- and deoxy-
hemaglobin. ONOO- potently reacts with most of the iron proteins including 
myoglobin, hemoglobin and cytochrome c oxidase (Cooper, 1999). 
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Fig 1.8 An overview of heme iron:NO interactions and their importance. 
 
 
NO, especially NO+ species, reversibly reacts with thiol groups (R-SH) as 
discussed in 1.2.1. It is now known that thiol-NO chemistry is relevant to immune, 
antimicrobial, smooth muscle relaxant and neuronal bioactivities (Gaston, 1999). The 
caspases are potential molecular targets of NO with respect to apoptosis. It was firstly 
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observed in cell-free in vitro studies that NO-related species dose-dependently inhibit 
recombinant caspases through S-nitrosation of an essential active site cysteine residue 
that is functionally conserved among these proteases (Dimmeler et al., 1997; Kim et 
al., 1998; Li et al., 1997). This inhibition was reversible and sensitive to reducing 
agents such as dithiothreitol (DTT) and glutathione (GSH). S-nitrosation was observed 
in almost all the 13 known mammalian caspases (Boyd and Cadenas, 2002). Two 
further studies established the physiological significance of this process. NO donors  
prevent apoptosis in HUVEC cells over-expressing caspase-3 by direct S-nitrosation of 
caspase-3 at the active site cysteine-163 (Rossig et al., 1999); Mannick et al. found 
that in human lymphocyte cell lines and MCF-7 cells, the inactive caspase-3 zymogen 
is also S-nitrosated at the same critical cysteine residue mediated by endogenously 
generated NO (Mannick et al., 1999). Fas-induced apoptosis in these cells involves the 
promotion of caspase activation by a dual process: de-nitrosation of the cysteine 
residue and cleavage of the zymogen to the active protease. The active caspase-3, in 
turn, could be further inhibited by S-nitrosation following an increase in the steady-
state level of NO. So S-nitrosation of caspases may be a major mechanism of NO 
mediated cell protection against apoptosis (Brune et al., 1998; Lipton, 1999), inhibiting 
both the initiator and executor caspases and therefore preventing receptor-mediated as 
well as mitochondria-mediated apoptosis .  
Besides the classical reaction of nitrosation (in which NO is transferred to –SH 
groups of a protein), NO is also able to enhance disulfide bonding of vicinal sufhydryl 
(thiol) groups of redox sensitive proteins. One example is the disulfide bonding in the 
redox sensitive modulatory site of the N-methyl-D-aspartate (NMDA) receptor 
complex, which is enchanced by NO nitrosation (Fig 1.9), thereby down-regulating  its 
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Ca2+ channel activity and desensitizing the signaling pathway activated by NMDA 


























Fig 1.9 Schematic model of reaction of NO (in S-nitrosocysteine form, upper panel) and nitroxyl  
ion (NO-, lower panel) with the NMDA receptor (Lipton, 1999). 
 
 
The best example of NO activating a classical signaling pathway via S-
nitrosation is the small guanine nucleotide binding protein H-Ras. S-nitrosation of a 
critical Cysteine (C118) residue causes guanine nucleotide (GDP/GTP) exchange that 
activates H-Ras. This results in the activation of a signaling pathway that includes 
ERK and NF-kappa B, and causes cellular proliferation and differentiation. The 
contribution of NO to the activation of Ras depends on a number of factors: the redox 
state of the cell (or subcellular region), the activation of the Ras pathway by other 
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effectors (like receptor tyrosine kinase) and the availability of competing targets of NO 
(Landar and Darley-Usmar, 2003). 
 
1.2.4 Understanding the paradoxical effects of nitric oxide on cell viability 
It is now clear that NO is able to exert either destructive or protective roles in 
different cell types. The consequence of NO exposure on cells depends on a number of 
poorly characterized factors. First of all, cell type plays an important role. 
Macrophages, thymocytes, neuronal cells, pancreatic islets, and some tumor cells are 
very sensitive to NO and undergo apoptosis or necrosis upon exposure to even low 
levels of NO. Other cell types (hepatocytes, human B lymphocytes, endothelial cells, 
cardiac myocytes, splenocytes, and ovarian follicles) are resistant to NO toxicity (Kim 
et al., 2000). Different cellular capacities to scavenge or to detoxify NO may be 
partially responsible for such variations in cell type susceptibility (Kroncke et al., 
1997). The differences in the activity of the whole cellular antioxidant system, 
consisting of catalase, superoxide dismutases, glutathione reductase, glutathione 
peroxidase, thioredoxin, thioredoxin reductase to supply reduction equivalents, e.g., 
NADPH via the hexose monophosphate shunt, may lead to survival or cell death after 
nitrosative stress (Kroncke et al., 1997). Cell type-specific inducible defense 
mechanisms against NO may also account for the susceptibility difference. Hsp70, 
MnSOD, HO-1, Cox-2 upregulation have been reported in response to NO in different 
cell lines and neutralize the damaging effects of NO (Bogdan, 2001; Demple, 1999; 
Kroncke et al., 1997). Since the transactivation of a specific gene depends on the 
different cellular contexts, it is expected that different cells exhibit different patterns of 
these defense mechanisms that may account for the varying cellular susceptibilities. 
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The level of NO exposure and composition of NO-derived reactive species (RNS) 
are other key factors in determining the effects of NO on cell viability. For example, 
low concentrations of NO prevent apoptosis in serum-starved PC12 cells while high 
concentrations lead to necrotic cell death (Kim et al., 1999). One of the mechanisms 
underlying apoptosis resistance is caspase nitrosation by NO (discussed in 1.2.3), 
which inhibits both initiator (e.g. caspase-8) and executor caspases (e.g. caspase-3) so 
that the cytochrome c induced initiating cell death pathways and the positive feedback 
amplification of apoptotic signaling arising from the downstream promotion of 
cytochrome c release by pre-activated caspase-3 are both greatly prevented (Boyd and 
Cadenas, 2002). It is worth pointing out that S-nitrosation is not exclusive and 
alternative mechanisms might also be important, depending on the cell-type and nature 
of the pro-apoptotic signals. That may partially explain why NO can inhibit caspases in 
some scenarios while activate caspases in the others. At high concentration of NO, the 
electron flux through mitochondrial respiratory chain is severely damaged (discussed 
in 1.2.1 and 1.2.2), excessive O2·- is generated and thus production of ONOO- is highly 
favored. Peroxynitrite further causes irreversible damage to mitochondria ATP 
synthase and aconitase, and promotes the permeability transition, cytochrome c release 
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Fig 1.10 The dual roles of NO on cell viability and the possible explainations (Brune et al., 1998). 
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1.3 AP-1 and programmed cell death 
1.3.1 Regulation of AP-1 activity as a transcription factor 
 
AP-1 (activator protein 1) is a homo- or hetero-dimer consisting of basic region-
leucine zipper (bZIP) proteins that belong to the Jun (c-Jun, JunB and JunD), Fos (c-
Fos, FosB, Fra-1 and Fra-2) and the closely related activating transcription factors 
(ATF2, LRF1/ATF3, B-ATF) subfamilies (Karin et al., 1997). These protein families 
contain three important domains: a transactivation domain (TAD), a DNA binding 
domain (DBD) and a leucine zipper region. The Jun proteins are most versatile and 
capable of forming Jun-Jun, Jun-Fos and Jun-ATF dimers. The dimerization occurs via 
hydrophobic interactions between the leucine zipper regions. Jun-Jun and Jun-Fos 
dimers bind TREs (TPA-responsive elements, 5’-TGAG/CTCA-3’), while Jun-ATF 
dimers prefer CREs (cAMP responsive elements, 5’-TGACGTCA-3’) (Hai and Curran, 
1991). A number of other bZIP proteins which can heterodimerize with Jun, Fos and 
ATFs have also been characterized (see review by Karin et al., 1997). 
AP-1 activity is induced by a broad range of extracellular stimuli including 
growth factors, hormones, cytokines, cell-matrix interactions, bacterial or viral 
infections and genotoxic agents (Shaulian and Karin, 2002). In general, the regulation 
of AP-1 activity occurs through: first, changes in gene transcription and mRNA 
turnover; second, effects on protein turnover; third, post-translational modification that 
modulate the transactivation potential; and fourth, interactions with other transcription 
factors that can either synergize or interfere with AP-1 activity. In the following 




1.3.1.1Transcriptional regulation of c-jun and c-fos expression  
 
Most of the genes encoding AP-1 components belong to “immediate-early” genes 
whose transcription is rapidly induced, independently of de novo protein systhesis 
following cell stimulation. Among them, the regulation of c-fos and c-jun transcription 
is best understood (Karin, 1995).  
c-jun is expressed in various cell types at low levels, and its expression is 
elevated in response to many stimuli. Induction is usually mediated through the c-jun 
TRE, which was recognized by c-Jun·ATF2 heterodimers (van Dam et al., 1993). 
Exposure of cells to UV irradiation, proinflammatory cytokines or growth factors 
results in activation of the JNK and p38 groups of MAPKs. JNKs and p38 can further 
phosphorylate c-Jun and ATF2, thus stimulating their transcriptional activity (Fig 1.10) 
(Karin, 1995).  
Compared with c-jun, the c-fos promoter region is more complicated. c-fos 
transcription can be stimulated very rapidly and transiently, partly due to the existence 
of several cis elements mediating c-fos induction. Proximal to the c-fos TATA box is a 
CRE that is potentially occupied by CREB (CRE-binding protein) or ATF proteins, 
which all mediate c-fos induction via cAMP- and Ca2+-dependent signaling pathways 
in response to neurotransmitters and hormones (Karin et al., 1997). The phenotypic 
similarities of c-fos-/- and ATF2-/- mice (Johnson et al., 1992; Reimold et al., 1996), 
both of which have defects in bone formation and the central nervous system, suggest 
that ATF2 may regulate c-fos expression in these tissues. However, the CREB-/- and 
CREM-/- mice displayed different phenotypes from c-fos and ATF2 null mice (Blendy 
et al., 1996; Hummler et al., 1994), suggesting that neither CREB nor CREM is critical 
in regulation of c-fos in vivo. Another cis element that regulates c-fos transcription is a 
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Sis-inducible enhancer (SIE) which is recognized by transcription factors of the STAT 
(signal transducer and activator of transcription) family which are activated by the 
JAK group of kinases. A third cis element is the serum-response element (SRE), which 
is recognized by a dimer of the serum-response factor (SRF) that recruits the ternary 
complex factors (TCFs). TCFs are important mediators of c-fos induction by a large 
variety of extracellular stimuli. For example, mitogen-induced c-fos transcription is 
largely dependent on ERK-mediated Elk (one component of the TCFs) 
phosphorylation and increase of its transcriptional activity; UV irradiation and IL-1-
induced c-fos transcription is through JNKs or p38-mediated Elk phosphorylation (Fig 
1.11) (Karin, 1995; Karin et al., 1997).  
CRE TATASIE c-fosSRE
JAK ERK;JNK PKA;CaMK






Fig 1.11 Regulation of c-jun and c-fos transcription. The cis-elements mediating c-jun and c-fos 
transcription in response to different stimuli are illustrated. The protein kinases that phosphorylate the 
transcription factors that interact with these elements are indicated. PKA, protein kinase A; CaMK, 
calmodulin-dependent kinase; SIE, Sis-inducible enhancer; CRE, cAMP response element (Karin, 1995).  
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Unlike c-Jun and c-Fos, ATF2 is a constitutively expressed. Activity regulation 
of ATF2 mainly occurs at the posttranslational level. 
1.3.1.2 Posttranslational regulation of c-Jun, c-Fos and ATF2 
 
The activities of AP-1 components (preexisting and newly-synthesized) are 
regulated by phosphorylation. This form of posttranslational modulation is best 
illustrated in c-Jun, c-Fos and ATF2. It is possible that other proteins in this family are 
also subject to similar regulation. 
The activity of c-Jun is primarily regulated by the JNK (c-Jun N-terminal kinase) 
family of MAP kinases by specific phosphorylation of serine 63 and 73 of c-Jun within 
its transactivation domain, resulting in a large increase in the ability of c-Jun to interact 
with the CBP/p300 family of transcription coactivators and to cause transcriptional 
activation (Karin, 1995).  c-Jun is also phosphorylated by ERK or GSK-3 at a cluster 
of sites located next to its basic region which can inhibit its DNA binding activity 
(Boyle et al., 1991; Chou et al., 1992; Minden et al., 1994).  
The sequence surrounding the N-terminal phospho-sites of c-Jun is conserved in 
the C-terminal activation domain of c-Fos, suggesting a similar mode of regulation. 
Thr-232, the homolog of Ser-73 of c-Jun, is phosphorylated by FRK (Deng and Karin, 
1994) and potentiates c-Fos transcriptional activity. The mechanism by which 
phosphorylation of Thr-232 enhances c-Fos transcriptional activity is less clear, 
perhaps through interaction with components in the transcription machinery as in the 
case of phosphorylation of Ser-63 and Ser-73 of c-Jun.  
ATF2 phosphorylation at Thr-63 and Thr-71 within its N-terminal transactivation 
domain is also proven to stimulate its transcriptional activity. Like c-Jun, ATF2 is also 
phosphorylated by the JNKs. Also, transactivation by ATF2 is also potentiated upon 
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binding of Rb or E1A, probably through recruitment of additional activation domains 
to the DNA-bound ATF2 dimers (Karin, 1995).  
1.3.1.3 Regulation of AP-1 activity by its interacting proteins 
 
Important AP-1 interacting proteins which may regulate its transcriptional 
activity are three different types of MAPKs (mitogen activated protein kinases) as 
discussed in 1.3.1.1 and 1.3.1.2, including JNKs, ERKs and p38s. These MAPKs are 
highly specific in selecting their substrates in stimuli-dependent fashions (Karin, 1995).  
Another protein that regulates AP-1 activity is a transcriptional coactivator 
called JAB1 (Jun activation domain binding protein 1). JAB1 efficiently interacts with 
c-Jun and JunD, irrespective of phosphorylation of c-Jun, but not with JunB (Claret et 
al., 1996). The mechanism by which JAB1 activates c-Jun and JunD is through 
stabilization of the complexes that these proteins form with the AP-1 sites. The 
selective interaction of JAB1 with c-Jun and JunD, but not with JunB, might account 
for the differential target gene activation by these proteins (Karin et al., 1997). Target 
gene specificity is also determined by other AP-1 interacting protein. In the case of the 
Jun-Fos dimer, it has been shown that interaction between the dimer and other bZIP 
proteins (Maf, NF-E2), non-bZIP DNA-binding proteins (NFAT, Smad) contributes to 
the functional specificity of Jun-Fos proteins (Chinenov and Kerppola, 2001). 
Besides positive regulation of AP-1 activity, negative regulatory mechanisms 
also exist. For example, TPA-induced AP-1 activity is inhibited by the interferon-
inducible p202 through inhibition of DNA-binding of c-Jun:c-Jun or c-Jun:c-Fos 
dimmers (Min et al., 1996). Another protein established to suppress AP-1 activity is 
JDP2 (Jun-dimerizing partners 2). JDP2 is associated with c-Jun in the cell and 
strongly inhibits c-Jun transcriptional activity (Aronheim et al., 1997). 
 31
1.3.2 Role of AP-1 in cell proliferation and differentiation 
 
 1.3.2.1 Role of AP-1 in cell proliferation  
 
Initially AP-1 was found to be a mediator of oncogenic transformation based on 
the following observations: AP-1 activity is induced by various oncogenic signals, 
including TPA, growth factors and oncogenic viruses. Transformation by activated Ras, 
Raf or MEK1 induces AP-1 protein expression (Jochum et al., 2001). The 
transforming activity of AP-1 suggests that it is involved in either stimulation of cell 
proliferation or suppression of cell death. Some of the key experimental data will be 
described implicating AP-1 proteins in growth control and transformation. 
1.3.2.1.1 AP-1 is an important regulator in cell proliferation 
 
Requirement of c-fos and c-jun for proliferation as well as cell cycle progression 
was demonstrated through inhibition of their expression using antisense RNA. 
Consistently, microinjection of antibodies against Fos and Jun prevented serum-
stimulated cell cycle re-entry in quiescent mouse fibroblasts (Shaulian and Karin, 2001; 
Shaulian and Karin, 2002). Studies using fibroblasts derived from fos and jun null mice 
partially supported the observations above. c-fos-/-fosB-/- fibroblasts showed reduced 
proliferation capacity while c-fos-/- or fosB-/- fibroblasts proliferated normally; 
moreover, c-fos-/-fosB-/- mice were smaller than their wild type counterparts while the 
single knockout mice developed normally (Brown et al., 1998; Brusselbach et al., 
1995). Similarly, a reduced fibroblast proliferation rate as well as smaller cell size 
were also characterized in junD-/- mice (Thepot et al., 2000). Among all the different 
AP-1 deficiencies, mouse embryo fibroblasts (MEFs) from c-jun-/- embryos bore the 
most severe proliferation defects (Johnson et al., 1993; Schreiber et al., 1999). The 
cells can only be passed in culture once or twice before entering premature senescence. 
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Furthermore, even after immortalization, they still proliferated at a much slower rate 
than the wild type cells (Shaulian and Karin, 2002). Although JNK-mediated 
phosphorylation of c-Jun within the transactivation domain dramatically enhances c-
Jun activity, it is only partially responsible for stimulation of cell proliferation, as c-
junAla63/73 fibroblasts have a proliferation defect less severe than that of c-jun-/- 
fibroblasts (Behrens et al., 1999). Besides the role in continuous cell proliferation, c-
Jun induction also seems required for cell cycle re-entry in UV-irradiated fibroblasts 
(Shaulian et al., 2000). While the wild type fibroblasts only undergo transient cell 
cycle arrest after UV exposure, c-jun-/- cells experience prolonged growth arrest and 
fail to resume proliferation. c-Jun is also important for proliferation in other cell types 
such as fetal hepatoblasts and contributes to liver regeneration. Collectively, AP-1 
activity is essential for cell proliferation. 
However, not all AP-1 proteins support cell proliferation. JunB, a Jun subfamily 
protein, has been shown to negatively regulate cell proliferation and antagonize c-Jun 
activity. Examples are: junB-/- MEFs proliferate normally, similar to the wild type cells; 
MEFs from junB transgenic mice showed limited proliferation capacity and a 
prolonged G1 phase when immortalized in culture; c-Jun-/- fibroblasts are deficient in 
keratinocyte proliferation while JunB-/- fibroblasts proliferate faster than wild type 
cells (Shaulian and Karin, 2002).  
The effects of JunD on cell proliferation are hard to understand. The junD-/- 
MEFs are defective in proliferation and display premature senescence partially due to 
increased expression of p19ARF, a tumor suppressor gene that enhances p53 activity.  In 
contrast, the immortalized junD-/- cells show an enhanced proliferation rate, probably 
arising from overexpression of c-Jun as a compensating mechanism and consequent 
cyclin D1 upregulation (Shaulian and Karin, 2002).  
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1.3.2.1.2 Mechanisms of AP-1 modulation of cell proliferation 
 
AP-1 proteins were shown to bind directly and activate the cyclin D1 promoter  
in transient transfections (Shaulian and Karin, 2001). This observation provides a 
possible connection between AP-1 family proteins and the cell cycle machinery. 
Indeed, the induction of cyclin D1 by serum is more efficient in wild type fibroblasts 
than in c-fos-/-fosB-/- double mutants (Brown et al., 1998). Consistently, reduced 
expression of cyclin D1 is also observed in c-jun-/- MEFs (Wisdom et al., 1999). 
However, this deficiency does not fully account for the apparent proliferation defects 
in the cells since overexpression of cyclin D1 can only partially restore the capacity of 
proliferation in the c-jun null MEFs. Instead, the defect of proliferation is able to be 
completely suppressed by simultaneous loss of p53 protein (Shaulian and Karin, 2002). 
Moreover, c-Jun acts as a direct suppressor of p53 transcription as well as inhibitor of 
p53 activity, resulting in a failure to activate p21Cip1 (a CDK inhibitor). As a 
consequence, p53 is accumulated in c-jun-/- cells through enhanced transcription of the 
p53 gene, leading to p21 expression and cell cycle arrest. Thus, c-Jun can stimulate 
cell cycle progression through two distinct mechanisms: direct induction of cyclin D1 
transcription and indirect repression of p21  transcription (Shaulian and Karin, 2002).  
As a c-Jun antagonist, JunB represses the cyclin D1 promoter (Bakiri et al., 2000) 
and furthermore, induces the transcription of p16INK4a (Passegue and Wagner, 2000), 
coding for a CDK inhibitor that inhibits Rb phosphorylation by CDKs and therefore 
G1 to S phase transition (Fig1.12).   
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1.3.2.1.3 AP-1 is a mediator of oncogenic transformation: the mechasnisms 
 
AP-1 proteins are actively involved in controlling cell proliferation through 
modulation of the cell cycle regulators, suggesting they could be potentially involved 
















Fig 1.12 Effects of AP-1 proteins on cell cycle regulation. AP-1 proteins control cell cycle progression 
by regulating the expression of key components of the cell cycle machinery. C-jun stimulates G1 to S 
phase transition by inducing cyclin D1 and repressing p53, which in turn reduces p21 levels. C-Fos and 
FosB have redundant functions in the stimulation of S phase entry and the induction of cyclin D1 
expression. JunB inhibits G1 to S phase progression by inducing p16 and repressing cyclin D1. JunD 
inhibits S phase entry and increases the numbers of resting cells by modulating the Ras/p53 pathways 
(Jochum et al., 2001).  
 
When expressed in vivo, c-Fos transforms chondroblasts and osteoblasts, 
contributing to c-Fos-induced tumorigenesis of the skeleton (Jochum et al., 2001). The 
oncogenic activity of c-Fos is dependent on its dimerization with Jun proteins as well 
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as DNA binding. The integrity of the structural motifs within its N- and C-terminal 
transactivation domains is also essential. c-Fos–induced transformation is partly 
mediated by induction of the enzyme DNA methyl transferase 1 (DNMT1), which 
downregulates the expression of negative growth regulators through methylation of 
their promoter region (Shaulian and Karin, 2002). FosB transforms fibroblasts in 
culture but this does not happen in vivo. Fra-1 and Fra-2 have weaker transforming 
activity compared to other Fos proteins (Jochum et al., 2001). 
c-Jun is able to cause oncogenic transformation in mammalian cells, but relies on 
coexpression with an activated oncogene such as Ras or Src (Schutte et al., 1989). 
Transformation by c-Jun requires the intact N-terminal transactivation domain and can 
be enhanced by c-Jun phosphorylation on Ser-63 and Ser-73 (Jochum et al., 2001), 
implicating c-Jun target genes as mediators of transformation. Several genes involved 
in the transforming activity of Jun proteins in CEFs (chicken embryonic fibroblasts) 
have been identified (Fu et al., 1999; Hartl et al., 2001) including JAC (Jun-activated 
gene in CEF) and HB-EGF (heparin-binding epidermal growth factor-like growth 
factor).  In addition, different dimerization partners of c-Jun have important influences 
on its transformation-related activities (Shaulian and Karin, 2002): the c-Jun:c-Fos 
dimer is efficient in transforming skeletal osteoblasts and induces anchorage-
independent growth; and the c-Jun:ATF2 dimer promotes  growth factor-independent 
growth. However, the differentially regulated target genes in these circumstances 
remained to be identified. Despite its oncogenic potential in vitro, c-Jun 
overexpression in transgenic mice does not lead to tumorigenesis (Grigoriadis et al., 
1993).  Unlike c-Jun, both JunB and JunD lack transforming activity and may instead 
act as anti-oncogenes. This is supported by the observation that junB-/- mice are 
susceptible to developing a disease resembling human chronic myeloid leukemia 
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(Passegue et al., 2001). This sensitivity arises from the increased levels of the GM-
CSFα receptor and of the anti-apoptotic proteins Bcl-2 and Bcl-XL, as well as 
decreased levels of the cell cycle inhibitor p16, suggesting that JunB inhibits 
proliferation and thus suppresses leukaemogenesis (Jochum et al., 2001). 
1.3.2.2 Role of AP-1 in cell differentiation 
 
Differentiation is an important process for multicellular organisms to generate 
functionally discrete organs/tissues. Temporal changes in gene expression that result in 
cellular biochemical alterations and growth arrest are primary requisites for terminal 
differentiation. The modulation of gene expression is associated with the activities of 
transcription factors which promote or inhibit gene transcription (Kang et al., 1998). 
Multiple roles of AP-1 proteins in differentiation are well characterized in the 
hematopoietic lineages (see review by Liebermann et al., 1998). 
Hematopoiesis is a process in which a hierarchy of hematopoietic progenitor 
cells in the bone marrow (BM) proliferate and terminally differentiate along multiple 
distinct cell lineages. During the process, cell proliferation, differentiation and 
apoptosis are well-balanced to reach homeostasis. It has been proposed that 
coordinated expression of lineage specific and cell specific transcription factors plays 
pivotal roles in converting the proliferative and differentiative signals into genetic 
programs which determine cell survival, growth, differentiation, and functional 
activation as well as cell death (Liebermann et al., 1998). Fig 1.13 summarizes the key 
transcription factors involved in these processes. 
In vitro studies indicate that AP-1 complexes are functionally involved in 
regulation of hematopoietic progenitor development along most of the myeloid 
lineages including the monocyte/macrophage, granulocyte, megakaryocyte and 
erythroid lineages. The evidence is the murine M1 myeloid leukemic cell line can be 
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differentiated into macrophages upon stimulation by IL-6 and LIF (leukemia inhibitory 
factor), during which c-jun, junB, junD were stably induced (Lord et al., 1993). 
Overexpression of c-fos in M1 cells results in a marked increase in the cell population 
capable of being induced to differentiate at much lower (50- to 100- fold) 
concentrations of IL-6 compared with the wild type cells; IL-6, a differentiation 
inducer of M1 cells, is also an AP-1 target gene (Ray et al., 1989) during 
differentiation; c-fos antisense oligonucleotides dramatically impaired the 
differentiation capacity of M1fos cells at low concentrations of IL-6 and also inhibited 
the ability of normal BM-derived myeloblasts to differentiate into mature macrophages 
or granulocytes induced by M-CSF (macrophage colony stimulating factor) and G-
CSF (granulocyte colony stimulating factor) (Lord et al., 1993).  
In vivo studies using c-fos null mice helped to establish a unique role of c-Fos in 
determining the differentiation and activity of progenitors of the osteoclast lineage 
(Johnson et al., 1992; Wang et al., 1992), a specific population of bone-forming cells 
which are of hematopoietic origin. c-fos-/- mice develop a bone disease osteopetrosis, a 
disorder characterized by defective osteoclast function and increase in skeletal mass, 
due to a complete block of osteoclastic progenitor cells to differentiate into mature 
functional osteoclasts. This defect is only limited to osteoclastic progenitor cells and 
maturation of cells of the osteoblast/chondrocyte lineages (multipotent mesenchymal 
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Fig 1.13 Hematopoietic lineages and transcription factors as well as the major hematokines 
essential for their development.  IL, interleukin; CSF, colony stimulating factor; G-CSF, granulocyte 
CSF; GM-CSF, granulocyte-macrophage CSF; M-CSF, macrophage CSF; LIF, leukemia inhibitory 




AP-1 proteins also modulate T- and B-cell development. T cell activation is 
responsive to IL-2. CREB undergoes rapid phosphorylation on Ser119 upon IL-2 
stimulation and facilitates AP-1 activation and subsequent IL-2 production, which 
drives T cells into cell cycle progression (Barton et al., 1996; Jain et al., 1994). In 
addition, c-Fos apparently plays a negative role in regulating B-cell development. 
Evidence came from the analysis of transgenic mice overexpressing c-fos. The 
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proliferation and development of B lineage cells is retarded in BM cell cultures 
obtained from transgenic mice constitutively expressing c-fos and blocked in BM cells 
obtained from transgenic mice expressing IFN (interferon)-inducible c-fos, upon 
stimulation with IFN (Liebermann et al., 1998).  
Besides, AP-1 proteins have been shown to enhance differentiation in melanoma 
and thus prevent the abnormal growth of melanoma cells (Kang et al., 1998), pointing 
out a possible target in tumor therapeutics. 
 
1.3.3 Role of AP-1 in cell death 
 
Although initial studies suggest a role for AP-1 proteins in promoting cell 
survival or suppressing cell death, there is evidence that AP-1 is implicated in 
triggering cell death. The earliest indication of apoptotic role of AP-1 came from the 
following observations: lasting induction of c-Fos in the brains of mice treated with 
kainic acid, an activator of glutamate receptor and inducer of hippocampal neurons 
apoptosis (Smeyne et al., 1993); robust induction of c-Jun before the onset of cell 
death after exposure of the cells to various genotoxic stresses such as UV irradiation 
(Devary et al., 1991) or alkylating agents.  
Direct proof that AP-1 is functionally involved in apoptosis came from the 
analyses of animals or cells lacking AP-1 expression or activity. It is now clear that 
AP-1 functions in apoptosis in several different scenarios: normal development and 
terminal differentiation to remove unwanted cells and maintain homeostasis; and 
pathology resulting from acute or chronic disorders. The role of AP-1 in these cases 
will be discussed in detail in the following paragraphs. 
Using fos-LacZ transgenic mice, Smeyme et al found a continuous high 
expression of fos-LacZ in skin, hair follicles and bone cells undergoing terminal 
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differentiation and culminating in apoptotic cell death (Smeyne et al., 1993). Also, in 
the ovary, fos-lacZ-positive follicular cells were associated with atreic follicles/corpora 
lutea that are degenerating while oocyte containing follicles were negative for fos-LacZ 
expression. Although indirect, these data suggested that AP-1 plays a general role in 
apoptosis during early development and postnatally, upon terminal differentiation of 
many cell types. Another example of AP-1 involvement in development-related 
apoptosis is in the neuronal system. About half of the original population of neurons is 
eliminated by apoptosis during the development of the nervous system (Ameyar et al., 
2003). This kind of cell death is critical for ensuring the correct connections in the 
brain and partly due to competition of neurons for limited amounts of trophic factors 
such as NGF. NGF deprivation causes a rapid JNK activation as well as c-Jun 
phosphorylation (Le Niculescu et al., 1999; Watson et al., 1998). Conditional 
knockout of c-Jun in sympathetic neurons enhanced the survival of the neurons, 
proving the essential role of c-Jun in NGF deprivation-induced apoptosis in neurons 
(Palmada et al., 2002). 
 Two well-documented examples of AP-1 involvement in enhancing apoptosis 
arising from pathology are: in neurons, upregulation of Bim or other BH3-only Bcl-2 
family members such as DP5/Hrk, in JNK/c-Jun dependent style may represent 
general mechanisms underlying neuronal apoptosis (Harris and Johnson, Jr., 2001; Lei 
and Davis, 2003; Whitfield et al., 2001). The obvious resistance of jnk3-/- and JunAA 
mice to epileptic seizures and neuronal apoptosis in the hippocampal region induced 
by kainic acid (Behrens et al., 1999; Yang et al., 1997) might be partially due to 
blockade of these pathways. More importantly, it was recently demonstrated that the 
neurotoxic β–amyloid peptide (Aβ), an important protein in the pathogenesis of 
Alzheimer’s disease, induced apoptosis of cerebral endothethlial cells via AP-1 
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activation and subsequent Bim induction (Yin et al., 2002). In lymphoid cells, JNK-c-
Jun-FasL is responsible for both the proper action of the immune system (in T-cell 
mediated cytotoxicity) and immune cell homeostasis (during the deletion of peripheral 
lymphocytes after the immune response) (Ameyar et al., 2003). It is worth pointing out 
that activation of the JNK-c-Jun-FasL pathway also results in apoptosis in other cell 
types such as neuronal cells or fibroblasts (Kolbus et al., 2000; Le Niculescu et al., 
1999), which respond to extrinsic cell death pathways.   
The function of AP-1 in the cellular response to genotoxic stress is less 
conclusive. There are several studies suggesting a proapoptotic role of AP-1 in UV-
induced cell death. jnk1-/-jnk2-/- MEFs are relatively resistant to UV (Tournier et al., 
2000); c-Jun-/- fibroblasts are resistant to alkylating agents as well as UV(Kolbus et al., 
2000b; Shaulian et al., 2000); dominant negative c-Jun reduces apoptosis in human 
monoblastic leukemia cells exposed to a variety of genotoxins (Verheij et al., 1996). 
However, other studies suggest a protective role of AP-1 against UV (Ivanov et al., 
2001; Wisdom et al., 1999). This may be mediated through cooperation with STAT3 
to suppress the transcription of fas.  
A clear example of the anti-apoptotic activity of AP-1 is in liver cells, since c-
jun-/- cells die from defects in hepatogenesis (Hilberg et al., 1993). AP-1 is suggested 
to suppress p53 thus enhancing cell survival through multiple mechanisms including 
modulation of p19Arf (a protein that stabilizes p53), direct inhibition of p53 
transcription or p53 activity as a transcription factor in DNA binding or substrate 
recognition specificity (see review by Ameyar et al., 2003).  Furthermore, some of the 
protective effects of AP-1 might be mediated through induction of bcl-3, whose 
product functions as a survival factor for growth factor-deprived T cells (Rebollo et al., 
2000). 
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Two models were proposed to explain the diverse effects of AP-1 on cell death 
and survival (Ameyar et al., 2003). Model 1: induction of AP-1 results in activation of 
various target genes, such as fasL, bim, or bcl-3 whose products either promote or 
suppress cell death. The balance between pro- and anti-apoptotic genes finally 
determines whether the cell dies or survives (Fig 1.14A). This balance may vary from 
one cell type to another, and may be dependent on the type and duration of stimulus 
used to activate AP-1, as well as on the activation of other transcription factors. This 
would help to explain the complicated and even paradoxical role of AP-1 in different 
conditions.  Model 2: AP-1 functions as a homeostatic regulator that keeps cells in a 
certain proliferative steady state. Changes in the environmental conditions may 
enhance AP-1 activity. Persistent activation of AP-1 in cells containing damaged DNA 
causes defective replication and may trigger apoptosis through the same mechanisms 
that induce cell death after constitutive expression of oncogenes. However, the 
activation of AP-1 in cells that are able to proliferate promotes cell proliferation and 
































Fig 1.14 Effects of c-Jun on apoptosis. (A) Direct effects of c-Jun on apoptosis through transcriptional 
regulation. The sum of all signals (pro- and anti-apoptotic gene products) determines the cell fate. (B) 
Indirect effects of c-Jun on apoptosis. C-Jun activation results in downregulation of p21 expression and 
thus allows the cell cycle to progress. However, the actual fate of cells will be determined by the extent 
of cell damage (Shaulian and Karin, 2002).  
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1.4 Thesis rationale 
Although the AP-1 family of transcription factors was one of the first identified 
in mammals, its physiological functions are still far from being elucidated, especially 
in terms of AP-1 function in cell death and survival. Under some circumstances, AP-1 
activation results in cell death while in others, activation of AP-1 protects the cell from 
death.  AP-1 activation has also been shown to have nothing to do with cell death or 
survival. Even more complex, AP-1 could have different or opposite functions in 
different types of cells in response to one single stimulus. It is proposed that the 
diverse effects of AP-1 on cell death and survival arise from activation of different 
group of target genes with pro- or anti-apoptotic properties and the balance between 
them determines the final outcome. The nature and duration of the stimuli, tissue origin 
and cell specificity are main determinants for the activation. However, identification of 
pathway-specific AP-1 target genes is still at an early stage. In our laboratory, the 
human neuroblastoma cell lines (SH-Sy5y and SHEP) are used as an in vitro model of 
neuronal cells to investigate the possible roles of AP-1 in response to NO. The main 
purposes of my research work are:  
1). To investigate the signal transduction pathways that mediate AP-1 activation 
in response to nitric oxide (NO) in neuroblastoma cells. Since AP-1 activity is 
posttranslationally regulated by MAPK, I focused on the study of MAPK; 
2). To identify the NO-inducible, AP-1-dependent target genes which mediate the 
function of AP-1 in response to NO in neuroblastoma cells. 
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CHAPTER 2       MATERIALS AND METHODS 
 
2.1 Chemicals and reagents 
Bovine serum albumin (BSA), ampcilin, kanamycin, penicillin-streptomycin, 
SNP, SIN-1, DETA-NO, pyruvate, NADH, NGF (7S), alphidicolin, TPA were from 
Sigma Aldrich. SB203580 was from Calbiochem. The Dual luciferase assay kit and β-
galactosidase assay kit were from Promega.  Acrylamide/Bis and non-fat milk were 
from Bio-Rad. DEVD-afc and z-DEVD-fmk were obtained from BACHEM. Other 
chemicals or reagents are individually mentioned in the following sections where are 
relevant. 
All antibodies used in the research are listed in table 2.1.    
 
Table 2.1 Antibodies used in the research 
Name Host/Clone Source 
c-Jun Rabbit/polyclonal Cell Signaling 
Phospho c-Jun (Ser 63) Rabbit/polyclonal Cell Signaling 
Phospho c-Jun (Ser 73) Rabbit/polyclonal Cell Signaling 
JNK Rabbit/polyclonal Cell Signaling 
Phospho JNK Rabbit/polyclonal Cell Signaling 
actin Goat/polyclonal Santa Cruz 
SgII Goat/polyclonal Santa Cruz 
Myc Mouse/monoclonal Invitrogen 
Bcl-2 Mouse/monoclonal Transduction Laborotories 
Caspase 3 Rabbit/polyclonal Pharmingen 
PARP Mouse/monoclonal Pharmingen 
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NCAM Mouse/monoclonal Chemicon 
 
2.2 Cell culture  
SH-Sy5y and SHEP cells were cultured in Dulbecco’s modified Eagle’s medium 
(DMEM, Sigma) supplemented with 4.5 g/L glucose, 10% (v/v) fetal bovine serum 
(FBS, Hyclone), 100 units/ml penicillin and 100 ng/ml streptomycin (Sigma) in a 
humidified incubator containing 5% CO2.  Stable cells were selected and maintained in 
hygromycin (BD Bioscience), G418 (Calbiochem) or zeocin (Invitrogen) accordingly. 
(See Table 2.2) 
 
2.3 Transfection of mammalian cells 
2.3.1 Transcient transfection using LIPOFECTIN 
 
Approximately 1-2 × 105 cells were seeded onto 6-well or 35-mm tissue culture 
plates 16 h before transfection. 6 µl of LIPOFECTIN (Invitrogen) was diluted into 100 
µl of opti-MEM medium (Invitrogen) and incubated at room temperature for 30-35 
min. 1-2 µg of plasmid DNA was diluted into 100 µl of opti-MEM medium and 
combined together with the LIPOFECTIN-opti-MEM mixture. The DNA-
LIPOFECTIN mixture was incubated at room temperature for 15 min and topped up 
with opti-MEM to 1 ml. Cells were rinsed with opti-MEM medium followed by 
incubation with the transfection mixture for 8-10 h at 37ºC.  Subsequently, the 
transfection mixture was removed and the cells were incubated for another 40 h in 




2.3.2 Stable transfection using LIPOFECTIN 
 
Approximately 6 × 105 cells were seeded onto 50mm tissue culture plates 16 h 
before transfection. 12 µl of LIPOFECTIN was diluted into 100 µl of opti-MEM 
medium and incubated at room temperature for 30-35 min. 5 µg of plasmid DNA was 
diluted into 100 µl of opti-MEM medium and combined together with the 
LIPOFECTIN-opti-MEM mixture. The DNA-LIPOFECTIN mixture was incubated at 
room temperature for 15 min and top-up with opti-MEM to 2 ml. Cells were rinsed 
with opti-MEM medium followed by incubation with the transfection mixture for 8-10 
h at 37ºC.  Subsequently, the transfection mixture was removed and the cells were 
incubated for 24 h in complete growth medium. After that, the medium was refreshed 
with selection medium. Selection medium was replaced every 2 or 3 days. About 3 
weeks later, resistant clones were picked up and cultured for further identification.  
 
Table 2.2 Stable cell lines used in the current study 
Cell lines Medium Description Source 
TAM67 DMEM/H SH-Sy5y cells stably transfected 
with TAM67 plasmids 
Dr. Zhiwei Feng 
JunAA 
/S63A/S73A 
DMEM/H SH-Sy5y cells stably transfected 
with JunAA/S63A/S73A plasmids 
Own construction
DN-jnk1/jnk2 DMEM/G SH-Sy5y cells stably transfected 
with DN-jnk1/jnk2 plasmids 
Own construction
Si-sgII DMEM/H SH-Sy5y cells stably transfected 
with sgII- siRNA plasmids 
Own construction
T-S DMEM/H,Z TAM67 cells stably transfected Own construction
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with sgII expression plasmids 
T-7B2 DMEM/H,Z TAM67 cells stably transfected 
with 7B2 expression plasmids 
Own construction
 
G: G418 at 100 µg/ml; H: Hygromycin at 50 µg/ml (TAM67) or 100 µg/ml (the 
others), Z: Zeocin at 100 µg/ml.  DMEM: Dulbecco’s Modified Eagle Medium. 
 
2.4 Molecular cloning 
2.4.1 Construction of expression plasmids 
 
The plasmid encoding dominant-negative c-Jun (denoted JunAA) was obtained 
from Dan Mercola (Sidney Kimmel Cancer Center, San Diego, CA, USA).  The 
plasmids bearing the dominant-negative S63A or S73A mutations in c-Jun were 
constructed by PCR-based mutagenesis based on the plasmid JunAA. The primers 
used were: S63A (F) 5’-GCT CAA GCT GGC GTC TCC CGA GCT GG-3’; S63A (R) 
5’-CCA GCT CGG GAG ACG CCA GCT TGA GC-3’; S73A (F) 5’-CCT CCT CAC 
CTC TCC CGA CG-3’; S73A (R) 5’-CGT CGG GAG AGG TGA GGA GG-3’, 
respectively. The Gal4-c-Jun transactivator and Gal4-luciferase reporter plasmids were 
purchased from Stratagene. The modified Gal4-c-Jun plasmids (S63A, S73A or JunAA) 
were constructed by cloning the transactivation domain of c-Jun (amino acids 1-221) 
bearing the S63A, S73A or JunAA mutations into the pFA-CMV vector from 
Stratagene. The pgl3-TRE and pgl3-CRE reporter plasmids and RPL-TK plasmid were 
kindly provided by S. Dhakshinamoorthy (Institute of Molecular and Cell Biology, 
Singapore). The plasmid encoding dominant-negative (DN)-JNK1 was provided by 
Roger J. Davis (Howard Hughes Medical Institute, University of Massachusetts 
Medical School, Worcester, MA), and the plasmid encoding DN-JNK2 was provided 
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by Dr. Shengcai Lin (Institute of Molecular and Cell Biology, Singapore). The 
plasmids encoding dominant-negative c-Jun (denoted TAM-67) was provided by R. 
Jaggi (University of Bern, Bern, Switzerland). The primers used for amplification and 
cloning  of the sgII promoter were: (F) 5’- CCG GTA CCG TAC GAA GCT TCC 
TTT CGA TTG CAA ATG AAT TTC-3’; (R) 5’- CCG CTC GAG GCT CCA CAG 
CAT ATT CCT CCC GTT CTC CGG G-3’. 200 ng genomic DNA from SH-Sy5y 
cells was used for amplification of the sgII promoter with expand Hifi DNA 
polymerase (Roche). The PCR product was cloned into pgl3-basic and pgl3-enhancer 
vectors (Promega) at KpnI and XhoI sites. The primers used for mutagenesis of CRE 
motif in sgII promoter were: (F) 5’-GCT GAA CCC GGA GTG GTC AGT GTG GC-
3’; (R) 5’-GCC ACA CTG ACC ACT CCG GGT TCA GC-3’. The mutant CRE motif 
is underlined. 
2.4.2 Preparation of Escherichia coli competent cells 
 
The DH5α, XL-blue E. coli strain was streaked onto an LB (pH 7.5) agar plate 
(containing 1% bacto-tryptone, 0.5% bacto-yeast extract, 1% NaCl, and 1.5% agar) 
without antibiotics and incubated at 37°C overnight.  A single colony was inoculated 
into 30 ml of LB and grown at 37°C with shaking.  The overnight culture was added to 
OD600 0.1 in 400 ml of LB and grown for approximately 3 h at 37°C to reach OD600 
0.3-0.6.  The bacterial culture was harvested by centrifugation at 4000 rpm for 10 min 
at 4°C.  The pellet was washed on ice in 100 ml of 100 mM CaCl2. Subsequently, the 
bacteria were centrifuged again at 4000 rpm for 10 min at 4°C. The pellet was 
resuspended in 8 ml of 100 mM CaCl2 with 10% glycerol. The competent cells were 
aliquoted and stored at –80°C. 
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2.4.3 DNA transformation 
 
The ligated DNA (5 µl, about 100 ng) or pure plasmid DNA (about 10 ng) was 
mixed with 100 µl of competent cells, which were pre-thawed on ice. After the mixture 
was incubated on ice for 30 min, the cells were heat-shocked for 90 seconds at 42°C 
followed by placing on ice for 10 min. For ampicillin-resistant plasmids, the cells were 
directly spread onto the LB agar plates containing 50 µg/ml ampicillin.  For plasmids 
with kanamycin resistance genes, 1 ml of LB was added to the heat-shocked cells 
followed by shaking at 37°C for 1 h. Before the cells were spread onto LB plates 
containing the appropriate antibiotic, a brief spin of the cells in a micro-centrifuge was 
performed to reduce the volume.  
 
2.4.4 DNA preparation 
 
Small-scale plasmid DNA isolation from E. coli cultures was carried out using 
the Rapid Plasmid Miniprep System (Marligen Bioscience, MD, USA) according to 
the manufacturer’s instruction.  The overnight bacterial culture was harvested by 
centrifugation at 14,000 rpm for 5 min, and the supernatant was discarded.  The cell 
pellet was completely resuspended in Cell Resuspension Solution [50 mM Tris-HCl 
(pH 7.5), 10 mM EDTA, and 100 µg/ml RNase A], followed by the addition of Cell 
Lysis Solution (0.2 M NaOH and 1% SDS), Alkaline Protease Solution and  
Neutralization Solution (4.09 M guanidine hydrochloride, 0.759 M potassium acetate 
and 2.12 M glacial acetic acid, pH 4.2).  The bacterial lysate was centrifuged at 14,000 
rpm for 10 min at room temperature, and the cleared lysate was transferred to a Spin 
Column.  After centrifugation for 1 min, the Wash Solution, diluted with 95% ethanol, 
was added to the Spin Column (162.8 mM potassium acetate and 27.1 mM Tris-HCl, 
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pH 7.5), followed by another centrifugation.  The wash procedure was repeated again 
before the plasmid DNA was eluted in an appropriate amount of TE or nuclease-free 
water.  
Large-scale plasmid DNA isolation was carried out by using the QIAGEN 
Plasmid Maxi Kit (QIAGEN) according to the manufacturer’s instructions.  Similar to 
the miniprep process, large volumes of bacterial culture were centrifuged into pellets 
and subsequently incubated with the resuspension, lysis and neutralization buffer 
sequentially. After clearing of the bacterial lysate by centrifugation, the supernatant 
was applied to a the pre-equilibrated QIAGEN-tip 500 column, followed by washing 
with wash buffer (1 M NaCl, 50 mM MOPS pH 7.0 and 15% isopropanol).  The 
plasmid DNA was eluted by elution buffer (1.25 M NaCl, 50 mM TrisCl pH 7.0 and 
15% isopropanol) and precipitated by 0.7 volumes of isopropanol.  The DNA pellet 
was washed with 70% ethanol, air-dried, and redissolved in a suitable volume of TE 
buffer or nuclease-free water. 
Genomic DNA isolation was carried out using the QIAGEN DNA mini kit. 
Cells from one 80 cm2 flask (NUNC, Denmark) were harvested, washed once with ice-
cold PBS and spun down at 2000 rpm for 5 min at 4ºC. The cells were resuspended in 
1 ml of PBS. 1 ml of ice-cold lysis buffer (1.28 M sucrose; 40 mM Tris·Cl, pH 7.5; 20 
mM MgCl2; 4% Triton X-100) and 3 ml of H2O were added into the cell suspensions. 
The mixture was incubated on ice for 10 min and subjected to centrifugation at 2000 
rpm for 15 min at 4ºC. The supernatant was discarded and the pellets were 
resuspended in 0.5 ml of lysis buffer and 1.5 ml of H2O. The mixture was vortexed and 
centrifuged at 2000 rpm for 15 min at 4ºC. The supernatant was discarded and 1 ml of 
digestion buffer (800 mM guanidine HCl; 30 mM Tris-Cl, pH 8.0; 30 mM EDTA, pH 
8.0; 5% Tween-20; 0.5% Tritin X-100) was added to resuspend the pelleted nuclei. 
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The nuclei were vortexed at maximum speed for 30 sec. 50 µl of protease was added 
into the nuclei followed by the incubation at 50ºC for 30 min. The sample was 
vortexed after lysis for 10 sec at maximum speed and applied to the pre-equilibrated 
QIAGEN genomic tip. The tip was washed with 3 × 1 ml of wash buffer (1.0 mM 
NaCl; 50 mM MOPS, pH 7.0; 15% isopropanol) and the genomic DNA eluted with 
prewarmed elution buffer (1.25 mM NaCl; 50 mM Tris.Cl, pH 8.5; 15% isopropanol). 
The DNA was precipitated by adding 0.7 volume of isopropanol to the eluted DNA 
and spun down. The DNA was air-dried and dissolved in TE or nuclease free H2O.  
 
2.5 Polymerase chain reaction (PCR) 
PCR for cloning purposes was performed by using the expand Hifi DNA 
polymerase (Roche) and the primers of the required sequences were synthesized by 
Genset Inc., Singapore.  Typically, to amplify DNA fragments, 20-50 ng of cDNA 
template in the PCR buffer was supplemented with 1.75 mM MgCl2, and mixed with 
250 µM of the deoxy-adenine, deoxy-cytosine, deoxy-guanine and deoxy-thymidine 
nucleotides (QIAGEN), 50 pM of the sense and anti-sense primers, and 2.5 Units of 
the Hifi DNA polymerase (Roche).  The reaction was carried out by 1 cycle of 
denaturation at 94°C for 2 min and primer annealing at 50-60°C for 30 sec (dependent 
on the primers used), followed by 30 cycles of DNA extension at 68°C for up to 2 min 
(dependent on the length of the PCR product), denaturation at 93°C for 15 sec, and 
primer annealing at 50-60°C for 30 sec.  A final cycle of DNA extension was carried 
out at 68°C for 7 min. For the PCR reaction for non-cloning purpose, Taq DNA 
polymerase (QIAGEN) was used.  
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2.6 Site-directed mutagenesis 
Point mutations were introduced into the plasmid cDNAs using the 
QuikChangeTM Site-Directed Mutagenesis Kit (Stratagene).  Complementary primers 
with point mutations were designed and used for extension in temperature cycling to 
generate mutant plasmids from the wild-type plasmid template.  The temperature-
cycling conditions involved 16 cycles of denaturation at 95°C for 30 sec, primer 
annealing at 50°C for 1 min, and extension at 68°C for 14 min (based on 2 min/kb of 
plasmid length).  The methylated wild-type template was removed from the newly 
synthesised, non-methylated plasmids by DpnI (New England Biolabs) restriction 
digest at 37°C for 1h.  The mutant plasmids were transformed in E. coli for clonal 
isolation and the mutations were confirmed by standard dideoxy termination 
sequencing. 
 
2.7 Sytox/Hoechst DNA staining  
S/H staining is an easy and quick way to distinguish between necrosis (passive 
cell death) and apoptotis (active, programmed cell death). Hoechst-33342 (Molecular 
Probes) is a blue membrane permeable DNA dye and sytox (Molecular Probes) is a 
green membrane impermeable DNA dye. When applied to cells: normal, healthy 
control cells with intact cell membranes display round and blue nuclei, whereas 
apoptotic (Sytox-impermeable membrane, only H-33342-stained) show blue strongly 
condensed/fragmented nuclei. In contrast, necrotic cells (damaged and therefore Sytox-
permeable membrane) appear swollen-greenish.  
After treatment, the Sytox/ Hoechst stain was added into the cell culture medium 
at final concentration of 500 nM and 500 ng/ml respectively and the cells were 
incubated at 37˚C for up to 5 min. Cells were then visualized under the Zeiss 
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epifluorescence microscope, and photos were taken with an attached Nikon Coolpix 
digital camera.  
 
2.8 Cell death assay 
Three different methods assaying cell death based on different principles were 
used in the research. Although the absolute values might be different by using these 
different methods, the pattern of death was similar. LDH is a stable cytoplasmic 
enzyme present in all cells and is rapidly released into cell culture medium when the 
plasma membrane is damaged. So the percentage of LDH release is proportional to 
percentage of damaged cells. WST is a tetrazolium salt which can be cleaved by 
mitochondria enzymes in metabolically active cells to form water-insoluble formazen 
which can be directly measured in an ELISA plate reader. So the healthier the cells are, 
the higher WST reading will be.  Crystal violet staining is an assay for cell attachment. 
For adherent cells, when cell death occurs, the cells will become detached thus cannot 
be stained due to the extensive wash step. 
LDH (lactate dehydrogenase) release assay. Cells (1-2 × 104 /well) were plated 
in 96-well plates and subjected to the desired treatments. After the treatment, the 
supernatants of the cells were collected, and the cell layer was lysed with an equal 
volume of lysis buffer (DME plus 0.1% Triton X-100). LDH activity in the supernatant 
and the lysate was quantitated. The cytotoxicity was calculated as percentage of LDH 
release by the ratio of supernatant/ (lysate + supernatant). 
WST assay. Cells (1-2 × 104 /well) were plated in 96-well plates and subjected to 
the desired treatments. After treatment, WST was added into each well at 1:10 dilution. 
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The cells were further incubated in a 37ºC incubator until the color changed and 
subjected to measurement at 420-480 nm. 
Crystal violet staining. Cells (1-2 × 104 /well) were plated in 96-well plates and 
subjected to the desired treatments. After the treatment, the cell culture medium was 
aspirated and cells were stained with a solution (20% methanol, 0.5% crystal violet) 
for up to 15 min at room temperature. The excess stain was removed completely by 
washing with distilled water many times. The cells were left to air-dry, and the stain 
was solubilized in 33% acetic acid solution. The absorbance was measured at 590 nm. 
 
2.9 Reporter assay 
For the Gal4-c-Jun reporter assay, 50 ng of Gal4-c-Jun activator plasmids (wild 
type, S63A, S73A or JunAA), 1 µg of Gal4-luciferase reporter plasmid and 10 ng of β-
galactosidase plasmid were co-transfected into SH-Sy5y cells in 6-well plates (1-2 × 
105 cells/plate). 40 h later, cells were treated with 2 mM SNP for the indicated times.  
Medium was removed and cells were washed three times with ice-cold PBS. Cells 
were harvested with 400 µl reporter lysis buffer (provided in the β-gal assay kit) and 
subjected to a short spin. 20 µl of supernatant was added to 100 µl luciferase substrate 
and the luciferase activity was immediately measured in a TD-20e luminometer. An 
aliquot of the same sample was used to determine β-galactosidase activity for 
normalizing luciferase activity obtained above.  
For the AP-1 reporter assay, 1 µg of pGL3-TRE or pGL3-CRE reporter 
plasmid and 10 ng of RPL-TK plasmid were cotransfected in cells seeded on 6-well 
plates. 40 h later, cells were either harvested directly or treated with 2 mM SNP for the 
indicated times and harvested as described above. Lysates were diluted ten times, and 
firefly luciferase activity was measured by adding 10 µl of diluted lysate and 100 µl of 
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firefly luciferase substrate. The Renilla luciferase activity, as internal control, was 
measured by adding Stop&Glo solution in the same tube. 
For the sgII promoter analysis, 1 µg of pGL3-sgII promoter reporter plasmids 
and 10 ng of RPL-TK plasmid were co-transfected cells seeded on 6-well plates. 40 h 
later, cells were either harvested directly or treated with 2 mM SNP for various times 
and harvested. Luciferase activity was measured as described above. 
 
2.10 Caspase-3 activity assay 
The activity of caspase-3-like proteases was measured using microtiter plates as 
described with modifications (Hentze et al., 2002). After SNP treatment, the cells were 
lysed in lysis buffer (20 mM Hepes, pH 7.5, 250 mM sucrose, 10 mM KCl, 1.5 mM 
MgCl2, 1 mM EDTA, 1 mM EGTA, and 1µg/ml each pepstatin, leupeptin and 
aprotinin), and the lysate was stored at –80°C if not for immediate use. The samples 
were diluted 1:10 with reaction buffer (60 µM fluorogenic substrate DEVD-afc in 50 
mM HEPES, pH 7.4, 1% sucrose, 0.1% CHAPS, 10 mM DTT) in a final volume of 
100 µl and incubated at 37°C for 30 min. Released afc was kinetically measured with a 
fluorescent spectrophotometer set at excitation wavelength of 400 nm and emission 
wavelength of 505 nm. For normalization, protein concentrations of the corresponding 
samples were estimated simultaneously by using the BCA reagents from Pierce 
Chemical Company. 1 µU/mg corresponds to 1 (µmol/mg) × min. 
 
2.11 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
The Bio-Rad Mini-PROTEAN II system was used for routine protein gel 
electrophoresis.  The resovlving gels included 6-15% acrylamide (29:1) (Bio-Rad), 
0.375 M Tris-HCl pH 8.8 and 0.1% (w/v) sodium dodecyl sulfate (SDS), and were 
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polymerized by the addition of freshly prepared 0.1% (w/v) ammonium persulfate and 
0.01% (v/v) TEMED.  The stacking gels included 4% acrylamide, 0.125 M Tris-HCl, 
pH 6.8, and 0.1% SDS, and were polymerized as described for the separating gels.  
Protein samples were mixed with an equal volume of 2X protein sample buffer [2X: 
125 mM Tris-HCl (pH 6.8), 4% SDS (v/v), 10% β-mercaptoethanol (v/v), 20% 
glycerol (v/v) and 0.4% bromophenol blue (w/v)], and heated at 95°C for 5 min before 
loading into the wells.  Electrophoresis buffer consisted of 25 mM Tris-HCl (pH 8.3), 
192 mM glycine and 0.1% SDS.  The gels were subjected to electroblotting onto 
polyvinylidene difluoride (PVDF) membrane (Millipore) for Western blot analysis. 
 
2.12 Western blot analysis 
After SDS-PAGE, the resolved proteins were electroblotted onto a PVDF 
membrane (pre-activated with methanol) using the Bio-Rad Trans-BlotTM system.  
Electroblotting was carried out in the transfer buffer composed of 25 mM Tris-base, 
192 mM glycine, and 20% methanol for 1 h at 4°C.  The membrane was then 
incubated in blocking buffer [PBS containing 5% (w/v) non-fat milk (Bio-Rad) or 
BSA and 0.1% (v/v) polyoxyethylene-sorbitan monolaurate (Tween-20, Sigma)] for at 
least 1 h.  The membrane was then incubated with the relevant antibodies diluted in 
blocking buffer to the optimized working concentrations for overnight incubation at 
4ºC.  Unbound antibodies were removed by extensive washing in PBS containing 0.1% 
Tween-20.  After incubation with the secondary antibody for about 2 h at room 
temperature and washing with PBS containing 0.1% Tween 20, the membrane was 
then developed using an enhanced chemiluminescence (ECL) kit. 
For reprobing of the same membrane with a different antibody, the immunoblot 
was incubated in stripping buffer [62.5 mM Tris (pH 6.8), 100 mM β-mercaptoethanol, 
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and 2% SDS] for 30 min at 60°C to remove the previous antibody.  The membrane was 
then re-blocked with blocking buffer and incubated with another antibody. 
 
2.13 Phospho-Jun and -JNK assay 
Cells were harvested after different times of 2 mM SNP treatment and lysed in 
200 µl of sample buffer (62.5 mM Tris-HCl, pH 6.8,  2% SDS, 10% glycerol, 0.1% 
bromphenol blue and 50 mM freshly added DTT). Sonication was needed to shear the 
genomic DNA and reduce the viscosity of the lysates. The sonicated lysate was then 
heated at 99°C for 5 min and subjected to centrifugation at 14,000 rpm for 5 min at 
4°C. 50 µl of the supernatants was separated on 12% of polyacrylamide gels and 
transferred onto PVDF membranes (Millipore). Detection of bands was performed 
using the Phototope®-HRP Western Blot Detection System (Cell Signaling). 
 
2.14 Peptide inhibition assay  
 The inhibition assay was carried out in SHEP neuroblastoma cells. D-TAT and 
D-JNKI1 peptides (Alexis Biochemicals, Switzerland) were added at final 
concentrations of 20, 50 and 100 uM into the medium. After 24 h, the medium was 
refreshed with peptides, and SNP was added at final concentration of 2 mM. At 
various times thereafter, cell death and c-Jun phosphorylation were measured as 
described above. 
 
2.15 RNA preparation 
Cells grown in monolayer were lysed directly in a culture dish. The media was 
decanted, TRI REAGENT was added, and the cell lysate was passed several times 
through a pipette. 1 ml of TRI REAGENT (Invitrogen) was used per 10 cm2 of culture 
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dish area. The homogenate was stored for 5 min at room temperature to permit the 
complete dissociation of nucleoprotein complexes. 0.2ml chloroform was added into 
the 1 ml of homogenate and the mixture was vortexed for 15 sec. The mixture was 
stored in room temperature for 15 min and subjected to centrifugation at 12,000 g for 
15 min at 4ºC. After centrifugation, the supernatant was carefully transferred into a 
fresh tube. RNA from the supernatant was precipitated by mixing with isopropanol 
(Use 0.5 ml of isopropanol per 1 ml of TRI REAGENT used for the initial 
homogenization.). The samples were stored at room temperature for 10 min and 
centrifuged at 12,000 g for 8 min at 4ºC. The supernatant was removed, and the RNA 
pellet was washed with 75% ethanol and centrifuged at 7,500 g for 5 min at 4ºC. The 
ethanol wash was removed and the RNA pellet was air-dried for 3-5 min at room 
temperature. RNA was finally dissolved in RNase-free H2O and frozen for further use. 
Total RNA (less than 250 µg) was diluted with RNase-free water to 250 µl, 
incubated with 15 µl of Oligotex resin (QIAGEN) and 250 µl of OBB. The mixture 
was thoroughly mixed by pipetting and incubated at 70ºC for 3 min followed by an 
incubation at room temperature for 10 min, allowing the hybridization between the 
oligo dT30 of the Oligotex particle and the poly-A tail of the mRNA. Oligotex:mRNA 
complexes were collected by centrifugation for 2 min at maximum 14,000 g. The 
supernatant was carefully removed by pipetting and the pellet was resuspended in 400 
µl of buffer OW2 by votexing, added onto a small spin column (supplied in the kit) 
which was placed in a 1.5 ml microcentrifuge tube and centrifuged for 1 min at 
maximum speed (14,000 rpm). The spin column was transferred to a new RNase-free 
1.5 ml microcentrifuge tube, and 400 µl of buffer OW2 was applied to the column. A 
short centrifugation was performed for 1 min at maximum speed, and the flow-through 
was discarded. The spin column was transferred to a new RNase-free 1.5 ml 
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microcentrifuge tube and 50 µl hot (70ºC) buffer OEB was pipetted onto the column, 
and 3-4 up and down pipetting steps were applied to resuspend the resin. A final 
centrifugation was carried out for 1 min at maximum speed to elute the mRNA. To 
concentrate the mRNA obtained, a precipitation step may be required. mRNA (at the 
starting volume of 50 µl) was mixed with 40 µl of 1×TE, 1 µl of glycogen (5 mg/ml), 
10 µl of 3M NaAc (pH 5.2) and 250 µl of 100% ethanol. The mixture was frozen at -
80ºC for 20 min and subject to centrifugation for 20 min at 12,000 g at 4ºC; the 
supernatant was removed and 250 µl of 75% ethanol was applied to wash the pellet. 
Centrifugation at 12,000 g for 5 min was performed, the supernatant was removed and 
the pellet was air-dried. The pellet was dissolved in an appropriate volume of RNase-
free water and frozen for further use. 
 
2.16 Microarray analysis 
SH-Sy5y cells and TAM67 stable cells were treated with 2 mM SNP for 6h or 
10h, total RNA was extracted using Trizol reagent (Invitrogen) and mRNA was 
purified using the OligotexTM mRNA kit (QIAGEN). Details are described in 2.16. The 
mRNA concentration was measured and its integrity was confirmed by PCR 
amplification of randomly selected genes. Microarray analysis was carried out by 
Incyte Genomics (St. Louis, MO, USA) under contract. 
 
2.17 Induction of neuronal differentiation 
Differentiation was induced as described with modifications (Jensen et al., 1992). 
Cells were plated on 60 mm tissue culture dishes at a density of 5-6×105 cells/dish. 
After overnight culturing, nerve growth factor (NGF-7S, Sigma) was added to the 
medium at a final concentration of 1µg/ml. On the second day, the medium was 
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refreshed with 5 µg/ml aphidicolin (Sigma) in the same medium. On the third day, the 
medium was refreshed with 1µg/ml NGF and 5 µg/ml alphidicolin. The medium was 
refreshed every two days with NGF and alphidicolin for 8-10 days. 
 
2.18 Preparation of whole cell lysates 
Cells were washed once with ice-cold PBS and lysed in lysis buffer [50 mM 
Tris·Cl, pH 8.0; 150 mM NaCl; 0.02% sodium azide; 1% Triton X-100 and freshly 
added protease inhibitor (Roche Applied Science)] on ice for 30 min and subjected to 
centrifugation at 14,000 rpm for 30min at 4°C. The supernatant was collected and the 
protein concentration was measured.  
 
2.19 Preparation of nuclear extracts 
Cells were harvested and washed twice with ice-cold PBS. Cell pellets were 
resuspended in buffer A (20 mM HEPES [pH 7.9], 1.5 mM MgCl2, 10 mM KCl, 0.5 
mM dithiothreitol and complete protease inhibitors) and homogenized in a Dounce 
homogenizer. After centrifugation at 600 g for 20 min, the pellets containing nuclei 
(supernatants, the cytoplasmic proteins, may be kept for further use) were resuspended 
in buffer C (20 mM HEPES [pH 7.9, 1.5 mM MgCl2, 420 mM KCl, 1 mM EDTA, 
25% glycerol, 0.5 mM dithiothreitol, and complete protease inhibitors) and incubated 
on ice for 20 min. The samples were centrifuged at 100,000 g for 20 min at 4ºC, the 
supernatants were collected as nuclear proteins. 
 
2.20 Detection of proteins released into the cell culture medium 
To detect protein release in the cell culture medium, serum-free culture medium 
was used to reduce background proteins. After treatment, the cell culture medium was 
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carefully collected and 50 µl of StrataCleanTM resin was added into the medium 
followed by vortexing for 15 sec. The mixture was centrifuged for 2 min at maximum 
speed at room temperature and supernatants were removed by pipetting. Pellets were 
resuspended in 50 µl of SDS sample buffer and equal volumes of samples were loaded 
on SDS-PAGE gels followed by western blot analysis.  
 
2.21 Eletrophoretic Mobility Shift Assay (EMSA) 
Reactions were conducted in a total volume of 20 µl. Typically, 5 µl of nuclear 
extracts (about 5 µg of protein) was added to the reaction buffer containing 100 mM 
KCl, 10% glycerol, 0.2 mM EDTA, 0.5 mM dithiothreitol, 0.5 mM 
phenylmethylsulfonyl fluoride, 1 µg of leupeptin/ml, 20 mM HEPES (pH 7.9), and 2 
µg of poly (dI-dC). The mixture was incubated on ice for 20 min, and 105 cpm (3,000 
Ci/mmol) of [γ-32P] ATP-labeled oligonucleotide probe with an AP-1 binding site (5’-
CGC TTG ATG ACT CAG CCG GAA-3’) was added. The oligonucleotide-protein 
mixture was incubated on ice for another 20 min and loaded on the 5% native 
polyacrylamide gels in Tris-glycine buffer (pH 8.5) for 3 h at 4ºC. The gels were dried 
and autoradiographed with intensifying screen at -80ºC. 
 
2.22 Annexin V staining 
Cells were treated with SNP for 16 h, harvested and washed twice with ice-cold 
PBS; and then were resuspended in 1X Binding Buffer (0.01 M HEPES, pH 7.4; 0.14 
M NaCl; 2.5 mM CaCl 2) at a concentration of ~1 x 10 6 cells/ml. Transfer 100 µl of 
the solution (~1 x 10 5 cells) to a 5 ml culture tube. 5 ul of Annexin V-FITC 
(Pharmingen) was added into the tube followed by gentle mixing and incubation for 15 
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min at room temperature in the dark. 400 µl of 1X Binding Buffer was added to each 
tube and sample was analyzed by flow cytometry without delay (within 1 hr). 
 
2.23 Semi-quantitative RT-PCR analysis 
SH-Sy5y and TAM67 stable cells were treated with 2 mM SNP for different 
times, total RNA was prepared (described in 2.16), followed by reverse transcription 
with Superscript II polymerase (Invitrogen Life Technologies) and PCR amplification 
with Tag DNA polymerase (QIAGEN). The PCR temperatures consisted of a 5 min 
denaturation step at 95 °C, followed by the indicated numbers of cycles at 95 °C for 30 
s, annealing for 30 s, and 72 °C for 45 s or 1.5 min according to the size of the 
amplified fragments. The numbers of PCR cycles, annealing temperatures and primers 
used were as follows.  
SgII, 25 cycles, annealing temperature 55 ˚C, forward: 5’-CGA CGG GAT CCA 
CCA TGG CTG AAG CAA AGA CCC ACT GGC TTG GAG-3’; reverse: 5’-GCA 
GCA CTC GAG CAT ATT TTC CAT TGC TCT CTT AGC AAT ATG C-3’. The 
primers were also used for cloning of SgII into pcDNA4/myc-His mammalian 
expression vector (Invitrogen Life Technologies). 
CGA, 25 cycles, annealing temperature 60 ˚C, forward: 5’-GCG CAA GCT TGC 
CAC CAT GCG CTC CGC CGC TGT CC-3’; reverse: 5’-GCG CGA ATT CGC CCC 
GCC GTA GTG CCT GC-3’. 
CGB (SgI), 35 cycles, annealing temperature 55 ˚C, forward: 5’-CGA CGA AGC 
TTG CCA CCA TGC AGC CAA CGC TGC TTC TCA GCC-3’; reverse: 5’-GCA 
GGG ATC CGC CCC TTT GGC TGA ATT TCT CAG C-3’. 
7B2, 25 cycles, annealing temperature 55 ˚C, forward: 5’-CGA CGA AGC TTG 
CCA CCA TGG TCT CCA GGA TGG TCT CTA CC-3’; reverse: 5’-GCA GGA ATT 
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CCT CTG GAT CCT TAT CCT CAT C-3’. The primers were also used for cloning of 
SgII into pcDNA4/myc-His mammalian expression vector. 
Actin, 20 cycles, annealing temperature 55 ˚C, forward: 5’-GAT GCA TTG TTA 
CAG GAA GT-3’; reverse:5’- TCA TAC ATC TCA AGT TGG GGG-3’. 
 
2.24 RNA interference 
Six different oligonucleotide sequences were chosen for the siRNA-mediated 
knock-down of SgII using the siRNA target finder software at www.ambion.com. The 
hairpin siRNA-encoding oligonucleotides were synthesized along with the loop 
sequence TTCAAGAGA and the BamH I and Hind III restriction sites (added to the 5’ 
and 3’ end of the DNA oligonucleotides respectively) and cloned into the siRNA 
vector pSillencerTM 2.1-U6 (Ambion, Austin TX) followed by sequencing. 
The six oligonucleotides are listed in table 2.3. 
 
Table 2.3 Lists of oligonucleotides used for sgII knock-down 
 Starting Position in SgII mRNA Sequence (5’ to 3’) 
1 551 (AA)ATAGTGGAGGAACAATATA 
2 619 (AA)ACTGACAGGACCAAACAAC 
3 823 (AA)TGAACAAATCAACGATGAG 
4 1492 (AA)CGACAAGGATCAAGAATTA 
5 1622 (AA)CAAATTGAGCAGGCCATCA 
6 1726 (AA)TGATGATACCCCAAATAGG 
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CHAPTER 3     JNK-dependent phosphorylation of c-Jun on 
Ser-63 mediates NO-inducible apoptosis in human SH-Sy5y 
neuroblastoma cells 
 
NO is a small, diffusible molecule with important physiological relevance such 
as regulation of neurotransmission and involvement in non-specific host defense 
against pathogens. There is accumulating evidence that excessive NO generation 
during strokes, ischemia or neurodegenerative diseases also contributes to neuronal 
cell death (Coyle and Puttfarcken, 1993; Torreilles et al., 1999). NO can exert its 
cytotoxic effects in diverse cell types via generation of highly reactive free radicals 
like peroxynitrite, which triggers downstream signal transduction pathways and lead to 
apoptosis or necrosis. However, the death pathways that are activated in neurons in 
response to massive NO production are not well understood.  
 
3.1 NO induces concentration-dependent apoptosis in SH-Sy5y cells  
Various NO donors have been widely used to study oxidative stress and cellular 
responses by mimicking endogenous NO generation (Brune et al., 1999). Many 
neuronal cell lines, including SH-Sy5y neuroblastoma cells, are highly sensitive to cell 
death induced by different NO donors (Feng et al., 2002n; Ghatan et al., 2000d; Oh-
Hashi et al., 1999). The mode of cell death under those circumstances can be either 
apoptosis or necrosis depending on the concentrations of the NO donors used. In the 
current study, SH-Sy5y cells were treated with different concentrations of SNP (a NO 
donor) for 15 hr and stained with Hoechst 33342 (a cell permeable dye for nucleic acid 
staining) plus Sytox (a non-permeable dye for nucleic acid staining). An obvious 
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nuclear condensation or chromatin fragmentations was observed at SNP concentrations 
higher than 1.5 mM (Fig 3.1A). Consistent with the above results, caspase-3 cleavage 
and activation, and PARP cleavage were also detected after a few hours treatment with 
2 mM SNP (Fig 3.1B). As DNA fragmentation, caspase-3 activation and PARP 
cleavage are the hallmarks of apoptosis, it can be concluded that under these 
experimental conditions, SNP-treated SH-Sy5y cells died by apoptosis.  
 
3.2 JNK activation correlates with c-Jun phosphorylation of Ser-63 in response to 
NO during apoptosis in SH-Sy5y cells 
A time-dependent increase in cell death was observed beginning around 8 h after 
addition of SNP to the SH-Sy5y cells (Fig 3.2A), and this increase correlated with the 
appearance of significant JNK kinase activity at 6 to 7.5 h after addition of SNP (Fig 
3.2B, upper panel). JNK phosphorylation seemed to occur majorly at 46 KDa isoform 
instead of 55 KDa isoforms, the significance of which was not clear. Since JNKs are 
the main upstream kinases for c-Jun NH2-terminal phosphorylation (Karin, 1995), I 
next tested whether the Ser-63 or Ser-73 residues of c-Jun were phosphorylated after 
SNP treatment by using specific antibodies detecting phosphoserine-63 or 
phosphoserine-73. A strong and sustained c-Jun phosphorylation on Ser-63 was 
observed at 6-8 h after the addition of SNP, whereas phosphorylation on Ser-73 was 
virtually undetectable (Fig 3.2C, upper and middle panel). In contrast, UV irradiation 
of SH-Sy5y cells resulted in similar levels of Ser-63 and Ser-73 phosphorylation (Fig 
3.2C). Thus, JNK activation and selective phosphorylation of c-Jun on Ser-63 both 
occurred around the onset of NO donor-induced apoptosis. Ser-63 phosphorylation and 
the death of SH-Sy5y cells both occurred at 1.5 mM SNP or higher. Concentrations of 
SNP lower than 1.5 mM induced neither cell death (Fig 3.1A and Fig 3.2E) nor Ser-63 
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phosphorylation of c-Jun (Fig 3.2D), indicating that c-Jun is phosphorylated only at the  
toxic concentrations of SNP. Excessive concentrations of SNP higher than 2.5 mM 
resulted in detectable Ser-73 phosphorylation that closely correlated with the onset of 
appreciable necrosis, indicating that predominant Ser-63 phosphorylation is an 
apoptosis-related phenomenon. 
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Figure 3.1. NO induces concentration-dependent apoptosis in SH-Sy5y cells.  (A) Nuclear staining: 
SH-Sy5y cells were treated with different concentrations of SNP for 15 h, Sytox/Hoechst 33342 was 
added and cells were visualized as described in the “materials and methods”. SH-Sy5y cells were treated 
with 2 mM SNP for different times, cells were harvested and whole cell lysates were prepared. Caspase-
3 cleavage (Fig B, left panel) and PARP cleavage (Fig C) were detected. Caspase-3 activation was also 
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Fig 3.2 JNK activation correlates with c-Jun phosphorylation of Ser-63 in response to NO during 
apoptosis in SH-Sy5y cells.  (A) SH-Sy5y cells were treated with 2 mM SNP for different times and 
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harvested, the percentage of dead cells was measured by LDH release assay as described in the 
“materials and methods”. Cells were treated with UV at 100 J/m2 following by 1 h incubation at 37ºC or 
2 mM SNP for different times, whole cell lysates were prepared and subjected to 12% SDS-PAGE gel 
and Western Blot analysis, detecting the phosphorylation of JNK (B) and c-Jun (C). JNK and c-Jun 
protein were revealed as a loading control. (D) Cells were treated with different concentrations of SNP 
for 10 h, whole cell lysates were prepared and subjected to 12% SDS-PAGE gel and Western Blot 
analysis, detecting phosphorylation of c-Jun.  Actin was revealed as a loading control. (E) Cells were 





3.3 c-Jun phosphorylation is not dependent on p38 kinase 
It has been reported previously that p38 MAP kinase can mediate c-Jun NH2-
terminal phosphorylation (Pramanik et al., 2003; Yamagishi et al., 2001). Furthermore 
the activation of p38 MAP kinase occurs in NO donor-induced apoptosis of various 
neuronal cells (Cheng et al., 2001; Ghatan et al., 2000). It was important to address the 
question whether c-Jun phosphorylation is p38-dependent. A p38 specific inhibitor 
SB203580 was used. SH-Sy5y cells were partially protected from SNP-induced 
apoptosis by SB203580, suggesting the involvement of p38 in SNP-induced cell death 
(Fig 3.3A). However, similar extent of c-Jun phosphorylation on Ser-63 was observed 
with or without SB203580, indicating c-Jun phosphorylation was not dependent on 
p38 (Fig 3.3B). 
 
3.4 Ser-63 phosphorylation alone mediates NO-induced apoptosis as well as c-Jun 
and AP-1 transactivation in response to NO in SH-Sy5y cells  
To investigate whether c-Jun phosphorylation contributes to NO-induced 
apoptosis, I stably transfected SH-Sy5y cells with plasmids encoding various 
dominant-negative forms of c-Jun. In one form, Ser-63 was mutated to alanine 
(denoted S63A), and in another Ser-73 was mutated to alanine (denoted S73A). In a 
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third form, both Ser-63 and Ser-73 were mutated to alanines (denoted JunAA), which 
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Fig 3.3 c-Jun phosphorylation is not dependent on p38. (A) SH-Sy5y cells were treated with 2 mM 
SNP with or without the p38 inhibitor, SB203580. 15 h later, the percentage of dead cells was measured 
by LDH release assay. (B) Cells were treated with 2 mM SNP for different times with or without 
SB203580. Whole cell lysates were prepared and subjected to 12% SDS-PAGE gel and Western Blot 
analysis to detect the phosphorylation of c-Jun. c-Jun was revealed as a loading control. 
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To exclude the possibility that highly overexpressed S63A, S73A, or JunAA 
might quench JNK activity by sequestering JNK in an abortive complex, I chose for 
further analysis independent clones in which S63A (Fig 3.4A upper panel), S73A 
(lower left panel) or JunAA (Fig 3.4A lower right panel) are expressed at levels only 
slightly in excess of endogenous c-Jun. Normal phosphorylation of endogenous c-Jun 
on Ser-63 in response to UV irradiation was still observed in two independent clones 
of S63A stable cells (Fig 3.4B). Analogous results were obtained in UV-irradiation-
treated S73A cells (Fig 3.4C). In addition, NO-induced phosphorylation of endogenous 
c-Jun on Ser-63 still occurred in two independent JunAA clones (Fig 3.4D). These data 
indicate that the expression of c-Jun mutated to S63A and/or S73A did not 
compromise endogenous JNK activity. 
I then compared the sensitivities of the above three different stable cells and 
vector control cells to NO donors and UV radiation. At any concentrations of SNP 
which were sufficient to induce apoptosis, several independent clones of S63A and 
JunAA stable cells showed markedly increased resistance to cell death compared with 
vector control cells. Importantly, various S73A stable cell lines failed to show 
resistance to NO compared with vector control cells (Fig 3.5A). S63A only partially 
rescued Sy5y cells from NO toxicity, suggesting involvement of other death pathways 
in addition of phospho-c-Jun. In contrast, neither S63A nor S73A stable cells were 
resistant to UV irradiation-induced cell death, whereas JunAA cells only showed a 
marginal increase in resistance to UV irradiation (Fig 3.5B). These data provide 
evidence that Ser-63 phosphorylation of c-Jun is important in NO-induced, but not UV 





















































Fig 3.4 Stable expression of S63A, S73 or JunAA does not inhibit endogenous c-Jun 
phosphorylation in SH-Sy5y cells. (A) Expression levels of the c-Jun proteins in the stable cell lines 
compared with vector control (V.C) cells. Upper panel, two clones of S63A. Lower left panel, two 
clones of S73A. Lower right panel, two clones of JunAA. Two independent clones of S63A, S73A 
stable cells and the vector control cells were irradiated by UV at 100 J/m2 followed by 1 h incubation at 
37ºC and whole cell lysates were prepared and subjected to 12% SDS-PAGE gel and Western Blot 
analysis, detecting the phosphorylation of c-Jun on Ser-63 (B) or Ser-73 (C). Actin was revealed as a 
loading control. (D) Two independent clones of JunAA stable cells and vector control cells were treated 
with 2 mM SNP for 10 h and whole cell lysates were prepared. Detection of c-Jun phosphorylation on 



















































Fig 3.5 Ser-63 phosphorylation alone mediates NO-induced apoptosis in SH-Sy5y cells. S63A, 
S73A and JunAA stable cells and vector control cells (V.C) were treated with different concentrations of 
SNP for 15 h (A) or different dosages of UV irradiation for 24 h (B), and the percentage of dead cells 
was measured by LDH release assay. Values are the mean ± S.D. determined from three independent 
clones of S63A, S73A or JunAA, each in triplicate. Statistical significance of the differences between 




Dual phosphorylation of c-Jun on Ser-63 and Ser-73 has been proved previously 
to lead to c-Jun dependent transactivation (Smeal et al., 1991), and accordingly 
mutation of both serine residues reduces the ability of c-Jun to transactivate target 
genes (Behrens et al., 1999). Because in the current study NO caused c-Jun 
phosphorylation predominantly on Ser-63, and since S63A and JunAA stable cells 
showed markedly increased resistance to cell death, the question was addressed 
whether Ser-63 phosphorylation alone can potentiate c-Jun and AP-1 transactivation. 
Using Gal4-c-Jun reporter system, I found Gal4-c-Jun (wild type) as well as Gal4-c-
Jun (S73A) were transactivated up to 4-fold in SH-Sy5y cells upon NO stimulation 
(Fig 3.6A). However, Gal4-c-Jun (S63A) and Gal4-c-Jun (JunAA) were completely 
inactive in transactivation (Fig 3.6A). In parallel experiments, transient transfections 
with AP-1 reporter plasmids revealed that NO-induced AP-1 activation of up to ~2.7- 
fold occurred in SH-Sy5y and S73A cells, but was absent in S63A cells (Fig 3.6B). 
Thus, the combined data from the c-Jun and AP-1 reporter assays indicate that the 
presence of Ser-63 (but not Ser-73) is required for NO-induced c-Jun/AP-1 
transactivation. These results also indicate that the S63A and JunAA constructs 
function as dominant-negatives by inhibiting gene transcription mediated by 
endogenous c-Jun. 
 
3.5 Caspase-3 contributes to NO-induced cell death downstream of c-Jun 
phosphorylation in SH-Sy5y cells 
Caspase-3 was found to be important for NO-induced apoptosis in SH-Sy5y cells 
because prevention of caspase-3 activity by z-DEVD (a selective caspase-3 inhibitor) 

























































Fig 3.6 Ser-63 phosphorylation is sufficient for c-Jun/AP-1 transactivation in response to NO in 
SH-Sy5y cells. (A) Gal4-c-Jun reporter assay. Different Gal4-c-Jun constructs bearing the unmodified 
(WT) c-Jun sequence, or S63A, S73A, JunAA mutations in the transactivation region of c-Jun, were 
cotransfected with a luciferase reporter plasmid together with β-galactosidase into SH-Sy5y cells. 40 h 
later, the cells were treated with 2 mM SNP for the indicated times and harvested. Luciferase activity 
was measured, and β-galactosidase activity was also measured as an internal control. (B) AP-1 reporter 
assay. The TRE-reporter plasmid was co-transfected with the RPL-TK plasmid into S63A, S73A and 
vector control (V-AA) stable cells. 40 h later, the cells were treated with 2 mM SNP for the indicated 
times and harvested. Firefly luciferase activity was measured, and Renilla luciferase activity was 




 50% (Fig 3.7A) and completely inhibit caspase-3 activity (Fig 3.7B), the levels of NO 
– induced Ser-63 phosphorylation of c-Jun were similar to those in the absence of z-
DEVD (Fig 3.7C), indicating that caspase 3 may act downstream of c-Jun 
phosphorylation. Two bands of phospho-c-Jun were occasionally observed, (Fig 3.7C) 
as has been noted previously (Le Niculescu et al., 1999b; Leppa et al., 1998). I next 
assayed caspase-3 activity in S63A and S73A stable cells after NO treatment and 
found that caspase-3 activity was inhibited efficiently in S63A cells compared with 
vector control cells, whereas S73A cells showed similar (or even slightly enhanced) 
caspase-3 activity under the same conditions (Fig 3.7D). Since caspase-3 contributes to 
NO-induced apoptosis in SH-Sy5y cells, these results provide additional evidence that 
c-Jun phosphorylation on Ser-63 (but not Ser-73) mediates NO-induced apoptosis, and 
indicate that caspase-3 contributes to apoptosis downstream of c-Jun phosphorylation. 
 
3.6 Evidence that c-Jun phosphorylation in response to NO is directly dependent 
on JNK in SH-Sy5y cells 
To provide more direct proof that JNK(s) play a role in c-Jun phosphorylation in 
response to NO, I stably transfected SH-Sy5y cells with DN-jnk1 or DN-jnk2 plasmids.  
At least two independent clones of both stable cells exhibited a greatly diminished or 
absent phosphorylation of c-Jun on Ser-63 (Fig 3.8A and B), indicating that JNKs are 
directly responsible for NO-stimulated c-Jun phosphorylation in SH-Sy5y cells. 
Various independently isolated DN-jnk1 and DN-jnk2 clones also showed increased 
resistance to apoptosis at three concentrations of NO donor (Fig 3.8C), that was 
quantitatively similar to that observed in S63A cells. A marked decrease of caspase-3 
activity, indicative of increased survival, was also observed in these stable cells. This 
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Fig 3.7 Caspase-3 contributes to NO-induced cell death downstream of c-Jun phosphorylation in 
SH-Sy5y cells. (A) SH-Sy5y cells were treated with 2 mM SNP in the absence or presence of the 
indicated concentrations of caspase-3 inhibitor z-DEVD for 15 h. Percentage of dead cells was measured 
by LDH release assay. (B) SH-Sy5y cells were treated with 2 mM SNP in the presence of 20 µM z-
DEVD for the indicated times, and caspase-3 activity was measured. In A and B, values are the mean ± 
S.D. determinded from three experiments performed in triplicate. (C) Cells were treated with 2 mM SNP 
in the absence or presence of z-DEVD for the indicated times. Whole cell lysates were prepared and 
subjected to SDS-PAGE gel and Western Blot analysis, detecting phosphorylation of c-Jun. C-Jun was 
revealed as a loading control. (D) S63A, S73A and vector control (V.C) cells were treated with 2 mM 
SNP for the indicated times, and the caspase-3 activity was measured as described in “materials and 
methods”. Values are the mean ± S.D. determined from three independent clones of S63A, S73A, each 
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Fig 3.8 Evidence that c-Jun phosphorylation in response to NO is directly dependent on JNK in 
SH-Sy5y cells. DN-jnk1 (A) or DN-jnk2 (B) stable cells and vector control (V-JNK) cells were exposed 
to 2 mM SNP for up to 10 h. Whole cell lysates were prepared and subjected to SDS-PAGE gel and 
Western Blot analysis, detecting the phosphorylation of c-Jun. (C) DN-jnk1 or DN-jnk2 stable cells and 
the vector control cells (V-JNK) were exposed to different concentrations of SNP for 15 h. The 
percentage of dead cells was measured by LDH release assay. (D) DN-jnk1 or DN-jnk2 stable cells and 
the vector control cells (V-JNK) were exposed to 2 mM SNP for different times, and caspase-3 activity 
was measured. In both (C) and (D), values are the mean ± S.D. determined from three independent 
clones of DN-jnk1 or DN-jnk2 cells, each in triplicate. 
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survival through the suppression of JNK-dependent Ser-63 phosphorylation of c-Jun 
and the inhibition of caspase-3 (Fig 3.8D).  
 
3.7 Evidence that JNK-mediated c-Jun phosphorylation on Ser-63 is a general 
phenomenon in NO-induced apoptosis of neuroblastoma cells 
It was important to find out whether JNK-mediated c-Jun phosphorylation on 
Ser-63 plays a general role in NO-induced apoptosis in neuroblastoma cell lines and to 
employ an alternative strategy to block JNK activity. In SHEP neuroblastoma cells, a 
strong Ser-63 phosphorylation of c-Jun began at around 8 h after SNP treatment, 
whereas Ser-73 phosphorylation was again virtually undetectable (Fig 3.9A). As with 
SH-Sy5y cells, UV irradiation caused similar extent of phosphorylation of both Ser-63 
and Ser-73 residues in SHEP cells (Fig 3.9A). A cell-permeable peptide, D-JNKI1 
(JNK inhibitory peptide 1), which specifically inhibits JNK activity (Bonny et al., 
2001), effectively blocked both Ser-63 phosphorylation (Fig 3.9B) and death of SHEP 
cells (Fig 3.9C). In contrast, a control cell-permeable peptide, D-TAT, neither 
prevented Ser-63 phosphorylation nor the death of SHEP cells (Fig 3.9B and 3.9C, 
respectively). These results offer additional evidence that the JNK family of protein 
kinases phosphorylate c-Jun in NO-induced apoptosis and argue that JNK-mediated c-
Jun phosphorylation on Ser-63 plays an important role in triggering the death of 
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Fig 3.9 Evidence that JNK-mediated c-Jun phosphorylation on Ser-63 is a general phenomenon in 
NO-induced apoptosis of neuroblastoma cells.  (A) SHEP cells were treated with 100 J/m2 followed 
by 1 h incubation at 37ºC or 2 mM SNP for the indicated times and lysed. Whole cell lysates were 
subjected to SDS-PAGE gel and Western Blot analysis, detecting the phosphorylation of c-Jun on Ser-
63 or Ser-73. SHEP cells treated with UV (100 J/m2) acted as a positive control for dual Ser-63 and Ser-
73 phosphorylation. c-Jun was revealed as a loading control. (B) SHEP cells were treated with 2 mM 
SNP plus different indicated concentrations of a cell-permeable JNK inhibitory peptide (D-JNKI1) or 
control peptide (D-TAT) for 10 h. c-Jun phosphorylation on Ser-63 was evaluated as described in A. (C) 
SHEP cells were treated with 2 mM SNP plus different indicated concentrations of D-JNKI1 or D-TAT 
peptides for 15 h, and the percentage of cell death was measured by LDH release assay. Values are the 





Previous reports have indicated that excessive generation of NO might be 
coupled to the activation of signal transduction cascades involving stressed-activated 
protein kinases and transcription factors. The activation of p38 MAP kinase occurs in 
NO-donor induced apoptosis of various neuronal cells (Cheng et al., 2001; Ghatan et 
al., 2000), which in one case involved p38 acting upstream of Bax to trigger the 
intrinsic (mitochondria) death pathway (Ghatan et al., 2000). There are many reports 
that NO can regulate AP-1 in the brain (Bogdan, 2001; Kataoka and Yanase, 1998), 
and various other studies have demonstrated that c-Jun/AP-1 can modulate apoptosis 
induced by diverse agents (Estus et al., 1994; Kihiko et al., 1999; Leppa et al., 2001; 
Potapova et al., 2001; von Knethen et al., 1999). However, the existence of NO-
induced JNK-c-Jun signaling and subsequent gene regulation in apoptosis has not been 
explored until now. In neurons, the JNK-c-Jun pathway is pro-apoptotic during 
neurotrophin factor withdrawal, kainate treatment, and potassium deprivation. This 
involves Ser-63 and Ser-73 phosphorylation (Behrens et al., 1999; Harada and 
Sugimoto, 1999; Le Niculescu et al., 1999), and it is accepted that the transcriptional 
activation of c-Jun in cell growth and development depends strictly on the dual 
phosphorylation of these amino acids (Behrens et al., 1999; Smeal et al., 1991).  
It is, therefore, notable I now show that Ser-63 (but not Ser-73) phosphorylation 
of c-Jun mediates NO-induced apoptosis of neuroblastoma cells. The evidence came 
from several complementary lines of investigation. Firstly, NO induced a strong 
activation of JNK, and only toxic concentrations of SNP induced phosphorylation of c-
Jun on Ser-63 prior to and at the onset of apoptosis. Secondly, S63A and JunAA stable 
cells (but not S73A cells) exhibited significantly increased resistance to apoptosis 
triggered by NO as measured by cell death and caspase-3 assays. Moreover, DN-jnk1 
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and DN-jnk2 stable cells showed increased resistance to NO correlating with markedly 
reduced Ser-63 phosphorylation and caspase-3 activation. My data suggest that JNKs 
are primarily responsible for phosphorylating c-Jun on Ser-63, which is further 
supported by my unpublished observation that a specific p38 MAP kinase inhibitor 
failed to block Ser-63 phosphorylation of c-Jun. Third, in a different approach, a 
highly specific JNK-inhibitory peptide blocked both exclusive Ser-63 phosphorylation 
and NO-induced apoptosis of SHEP neuroblastoma cells.   
Might one or both of the JNKs (1 and 2) directly phosphorylate substrates other 
than c-Jun and thereby contribute to apoptosis? Although still controversial, there is 
evidence that JNK-mediated phosphorylation of p53, p66shcA or Bcl-2 family members 
is pro-apoptotic in various different contexts (Buschmann et al., 2001; Fan et al., 2000; 
Kharbanda et al., 2000; Le et al., 2001; Yamamoto et al., 1999). However, I showed 
here that JNK activity is present at normal levels in S63A, JunAA and S73A cells, 
arguing that alternative potential JNK death substrates other than c-Jun would still be 
phosphorylated under conditions in which S63A protects from NO killing. Thus Ser-63 
of c-Jun is the important target in the NO-inducible killing pathway. It is not known 
why NO induces only Ser-63 phosphorylation, but it is worth speculating. There are 10 
known isoforms of JNKs, and NO might activate one isoform that only targets Ser-63. 
Alternatively, NO might activate a Ser-73 phosphatase; or putative NO-mediated 
chemical modification (e.g. nitrosylation) of c-Jun could preferentially block Ser-73 
phosphorylation.   
What is the pathway by which Ser-63 phosphorylation of c-Jun connects to 
caspase-3 activation and mediates apoptosis? There are two major possibilities. First, 
Ser-63 phosphorylation might activate c-Jun, which then transactivates death genes (or 
suppresses protective genes). This is strongly supported by the results of the Gal4-c-
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Jun and AP-1 reporter assays which show that the S63A mutation alone abolishes 
transactivation. These assays also indicate that c-Jun is a crucial component of an AP-1 
complex activated by NO, in agreement with antibody supershift experiments 
demonstrating c-Jun protein is abundant in AP-1 complexes after NO stimulation 
(Feng et al., 2002). Speculatively, Ser-63 phosphorylation might regulate a different 
set of target genes compared with dual phosphorylated or non-phosphorylated c-Jun, 
resulting in a shift to pro-cell death gene expression. It is worth considering the known 
c-Jun-regulated genes that are thought to play roles in neuronal apoptosis (Mattson et 
al., 2000; Pennypacker, 1997; Pennypacker, 1995; Shaulian and Karin, 2001; Shaulian 
and Karin, 2002; Tong et al., 1998). Among the stronger candidates are hrk, bim and 
fasl, which are pro-apoptotic (Harris and Johnson, Jr., 2001; Kasibhatla et al., 1998; 
Kolbus et al., 2000; Le Niculescu et al., 1999; Morishima et al., 2001; Whitfield et al., 
2001), but other possible genes are bcl-3 and GAP43 (Haas et al., 2000; Rebollo et al., 
2000). The second, perhaps less likely, possibility is Ser-63 phosphorylation may lead 
to apoptosis through transcriptional repression due to actions of c-Jun that suppress or 
antagonize other transcription factors (Herdegen and Waetzig, 2001).  
Recently, single phosphorylation of one of the two serine residues of c-Jun N-
terminal domain has been published (Yu et al., 2003). In cultured sympathetic neurons 
both deprivation of nerve growth factor (NGF) and deprivation of glial cell line–
derived neurotrophic factor (GDNF) results in massive cell death. But the underlying 
mechanisms are different.  Serine 73 of c-Jun was phosphorylated in both NGF- and 
GDNF-deprived neurons, whereas serine 63 was phosphorylated only in NGF-deprived 
neurons. Although there was no extensive study on the biological significance of Ser73 
phosphorylation of c-Jun in GDNF withdrawal induced cell death, it did provide 
additional evidence that under certain circumstances, single phosphorylation of c-Jun 
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can occur, and may have important physiological relevance. Furthermore, the 
important role of serine 63 phosphorylation in the cellular response to oxidative stress 
has been proposed (Madsen et al., 2004). Long-lived Snell Dwarf mice respond to 
oxidative stress induced by 3-NPA differently compared to their wild type littlemates 
(3-NPA is an irreversible inhibitor of succinate dehydrogenase, a component of 
mitochondira complex II, that generates free radicals). A significantly lower response 
in the MEK-ERK kinase cascade and a complete lack of c-Jun phosphorylation on 
serine 63 were observed in Snell Dwarf mice but not in wild type mice, suggesting a 
role of serine 63 in mediating an oxidative stress response. This altered management of 
oxidative stress may also provide an explanation for the extended longevity in dwarf 
mice, due to the role of oxidative stress in aging (Migliaccio et al., 1999; Sampayo et 
al., 2003). 
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CHAPTER 4    sgII, an AP-1 target gene, is a new class of 
proteins that mediate neuroprotection from NO-induced 
apoptosis and NGF-induced neuronal differentiation in SH-
Sy5y cells 
 
AP-1 transcription factors can regulate cell viability in culture, showing high 
complexity and even apparent contradictions depending on the cell type analyzed and 
stimuli exerted on cells. The diverse effects of AP-1 on cell death and survival 
probably arise from the diversity of AP-1 dimers as well as activation of different 
groups of pro- or anti-apoptotic target genes (Herdegen et al., 1997; Karin et al., 1997; 
Shaulian and Karin, 2002; Wisdom, 1999).  However, the molecular targets of AP-1 in 
cell death and survival are incompletely understood. Notably, AP-1 activity is 
enhanced in the CNS under pathological conditions such as acute or chronic neuronal 
disorders, suggesting a functional correlation of AP-1 and pathophysiology in these 
scenari. But downstream events, in terms of AP-1 target genes, are still unclear. 
Secretogranin II (SgII), an abundant component of neuroendocrine granules, 
might be regulated by AP-1 because of a conserved cyclic AMP response element 
(CRE) motif in its promoter that is important for both basal and regulated transcription 
of sgII (Desmoucelles et al., 1999; Mahata et al., 1999; Mahata et al., 2002; Scammell 
et al., 2000). Besides its classical function with relevance to secretion, there is growing 
evidence that SgII also involves in other cellular events such as modulation of 
neurotransmission, inflammatory responses and neuronal differentiation (Fischer-
Colbrie et al., 1995; Taupenot et al., 2003).   
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4.1 Dominant-negative c-Jun (TAM-67) sensitizes SH-Sy5y cells to NO-induced 
apoptosis 
From my previous study, it is known that Ser-63 phosphorylation of c-Jun 
mediates NO-induced cell death in neuroblastoma cells. Since phosphorylation of Ser-
63 and Ser-73 are dispensable for c-Jun activity, it is worth of looking into the global 
role of c-Jun/AP-1 in NO-induced cell death. To address this question, another 
dominant-negative form of c-Jun, TAM-67, was adopted. TAM-67 lacks most of the 
transactivation domain (TAD) of c-Jun and is able to inhibit the global function of 
endogenous c-Jun and AP-1through a competitive mechanism (Brown et al., 1994).  
Since components of AP-1 dimers can vary under different circumstances, it is 
important to know whether c-Jun is part of the AP-1 complex stimulated by NO. 
Besides usage of a c-Jun reporter assay (described in section 3.4), another approach, 
EMSA and supershift, was used. NO was able to increase AP-1 affinity to its 
consensus binding motif in a time-dependent style in an in vitro binding experiments 
as described in the “materials and methods”, starting from 2 h and reaching its peak 
about 8 h after SNP addition (Fig 4.2, left panel).  To determine whether c-Jun is 
present in this AP-1 complex, nuclear extracts from the 8 h time point were incubated 
with the AP-1-specific oligonucleotide with or without antibody against c-Jun.  As 
shown in Fig 4.2, right panel, AP-1 binding was completely blocked in the presence of 
c-Jun antibody, suggesting that c-Jun is a crucial component of the AP-1 complex 
induced by SNP. Dr. Zhiwei Feng contributed the supershift data (Feng et al., 2002).  
To clarify the global function of AP-1 in NO-induced apoptosis, Dr. Zhiwei Feng 
generated stable SH-Sy5y cell line expressing TAM-67 (Fig 4.3A). As mentioned 
earlier, TAM-67 has 104 amino acids deleted from the TAD of c-Jun and is able to 
dimerize efficiently with Fos, Jun and ATF-2 family proteins and bind the AP-1 
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consensus motif. Theoretically it can quench or inhibit endogenous AP-1 activity as 








































Fig 4.1 Inhibition of TAM-67 on endogenous AP-1 through competitive mechanisms. (A) TAM-67 
is able to dimerize with itself, occupies the AP-1 binding sites on the target gene promoter region and 
thus “kick the endogenous AP-1 out”. This is called a “blocking mechanism”. (B) TAM-67 is also able 
to dimerize with AP-1 subfamily proteins such as Jun or Fos, which then occupy the AP-1 binding sites 
on the target gene promoter region and thus prevent functional dimerization between wild type AP-1 









Fig 4.2 NO stimulates AP-1 activity in SH-Sy5y cells, and c-Jun is the major component of the AP-
1 complex. DNA bandshift analyses in native polyacrylamide gels were performed using an 
oligonucleotide containing consensus AP-1 motif. Left panel, nuclear extracts of SH-Sy5y cells were 
prepared at the indicated times after 2 mM SNP treatment. Right panel, supershift analyses using c-Jun 
antibodies. Nuclear extracts were prepared from SH-Sy5y cells treated with 2mM SNP for 8 h. Lane 1, 1 
µg of polyclonal antibody against c-Jun was added before the AP-1 oligonucleotide. Lane 2, no c-Jun 
antibody was added (Feng et al., 2002). 
 
 
To establish that TAM-67 is functional when expressed in SH-Sy5y cells, I 
compared the endogenous AP-1 activity in vector control cells and TAM-67 stable 
cells. AP-1 recognizes two types of consensus motif defined as TRE (TPA-responsive 
element, 5’ TGAC/GTCA3’) and CRE (cAMP-responsive element, 5’TGACGTCA3’). 
Reporter plasmids bearing either TRE or CRE as enhancer element for luciferase gene 
expression were transfected into vector control cells and TAM-67 stable cells, and 
luciferase activity was measured. As shown in Fig 4.3B, TAM-67 overexpression 
caused a dramatic inhibition of both TRE- and CRE-mediated reporter gene 
expressions. These data suggest that TAM-67 expression causes a global blockage of 
AP-1 mediated transcription in SH-Sy5y cells. Utilizing TPA (a classical AP-1 
activator), I also found that besides basal AP-1 activity, inducible AP-1 activity was 






















































Fig 4.3 TAM-67 stable expression in SH-Sy5y cells blocks the endogenous AP-1 activity. (A) 
Western blot analysis of SH-Sy5y cells stably expressing TAM-67 constructs. Lane 1, vector control 
cells. Lane 2, cells overexpressing TAM-67 (Feng et al., 2002). The positions of parental c-Jun and 
TAM-67 (a truncated form of c-Jun) are shown with an arrowhead. (B) Endogenous AP-1 activity in 
parental and TAM-67 stable SH-Sy5y cells. CRE- or TRE-reporter plasmids were co-transfected with 
RPL-TK plasmids into two different cell lines. 40 h later, cells were harvested and firefly luciferase 
activity was measured. Renilla luciferase activity was measured as an internal control. (C) TRE-reporter 
plasmids were co-transfected with RPL-TK plasmids into two cell lines. 40 h later, cells were treated 





Since AP-1 was shown to play a role in apoptosis under different circumstances, 
it was important to elucidate the function of AP-1 in NO-induced apoptosis in SH-
Sy5y cells. The sensitivity of vector control cells and TAM-67 stable cells to NO was 
compared. TAM-67 stable cells were markedly more sensitive to SNP-induced 
apoptosis than vector control cells at different concentrations (Fig 4.4A). To 
independently verify the difference in sensitivities of vector control and TAM-67 
stable cells to SNP, the externalization of phosphatidylinositol was quantitated by 
flow-cytometry-based annexin V staining. In most normal, viable eukaryotic cells, the 
negatively charged phospholipid phosphatidylserine (PS) is located in the cytosolic 
leaflet of the plasma membrane lipid bilayer. PS redistribution from the inner to the 
outer leaflet is an early and widespread event during apoptosis. Annexin V is a 35 kDa 
phospholipid-binding protein and has a high affinity to PS in the presence of 
physiological concentrations of calcium (Ca2+). In contrast to vector control cells, there 
was appreciable annexin V staining of TAM-67 cells, which again shows that 
suppression of AP-1 activity sensitizes SH-Sy5y cells to cell death induced by SNP. 
Similar results were obtained with an alternative NO donor, SIN-1, which also kills 
SH-Sy5y cells by apoptosis. Figure 4.C shows that the SIN-1-induced death of TAM-
67 cells was markedly higher than that of vector control cells (data was contributed by 
Dr Zhiwei Feng), confirming that blocking of AP-1 function sensitizes SH-Sy5y cells 
to NO toxicity. 
 
4.2 Protective gene expression is partially responsible for counteracting NO-
toxicity 
It is well established that NO regulates gene expression (Bogdan, 2001), but it is 











untreated 1.5 mM SNP
 
Fig 4.4 TAM-67 over-expression sensitizes SH-Sy5y cells to NO toxicity. (A) Vector control cells 
and TAM-67 cells were treated with the indicated concentrations of SNP for 16 h, and the percentage of 
cell death was quantitated using crystal violet staining as described in the “materials and methods”. 
Values were the mean and S.D was from three experiments performed in triplicate. (B) Cell death was 
determined by flow cytometry using annexin V staining to detect externalized phosphatidylserine (PS). 
Vector control cells and TAM-67 cells were left untreated or treated with 1.5 mM SNP for 16 h. M1 
marks the positions of the annexin V-stained cells. (C) Vector control cells and TAM-67 stable cells 
were treated with the indicated concentrations of SIN-1 for 16 h, and the percentage of cell death was 
quantitated using crystal violet staining (Feng et al., 2002).  
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apoptosis. Inhibition of  transcription or translation in SH-Sy5y cells by nontoxic doses 
of actinomycin D (AD) or cycloheximide (CHX) sensitized the cells to NO-induced 
cell death (Fig 4.5), suggesting that new or continuous gene expression is required for 
protection of these cells from NO toxicity. 
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Fig 4.5 Putative protective genes counteract NO toxicity in SH-Sy5y cells. SH-Sy5y cells were 
treated with SNP alone or together with two different concentrations of actinomycin D (AD) or 
cycloheximide (CHX) for 16 h. The percentage of cell death was measured as in Fig 4.4 by crystal violet 
staining. Values were the mean and the S.D was from three experiments performed in triplicate.  
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4.3 sgII, a potential AP-1 target gene, shows an NO-inducible and AP-1- 
dependent expression pattern in SH-Sy5y cells 
Based on the observations described above, TAM-67 overexpression leads to 
dramatic sensitization of SH-Sy5y cells to NO-induced cell death, and inhibition of 
transcription as well as translation could render the cells more sensitivity to NO. 
Furthermore, since TAM67 overexpression caused a massive blockade of AP-1 
mediated transcription in SH-Sy5y cells, I hypothesized that some neuroprotective 
gene(s), whose expression is AP-1 dependent, could be involved in counteracting NO 
killing. To identify these gene(s), a microarray analysis was carried out, comparing the 
gene expression profiles in 6hr or 10hr SNP-treated SH-Sy5y cells and TAM67 stable 
cells. At 6 and 10h after SNP treatment, sgII mRNA was respectively 5.2 and 17.7-fold 
lower in the TAM67 cells compared to the SH-Sy5y cells (Fig 4.6A), suggesting that 
c-Jun/AP-1 may be involved in the NO-induced transcriptional induction of the sgII 
gene.   
Semi-quantitative RT-PCR confirmed and extended the microarray results, 
showing that basal and NO-inducible sgII mRNA expression was markedly reduced in 
TAM67 cells compared to SH-Sy5y cells treated for various times with either NO 
donor, SNP or DETA-NO (Fig 4.6B). Since NO stimulated CRE activity in SH-Sy5y 
cells (Fig 4.7A), and a CRE element in the human sgII promoter region is important 
for tissue-specific and inducible expression of the gene (Desmoucelles et al., 1999; 
Mahata et al., 2002), I addressed the question whether the CRE located within the sgII 
promoter is sufficient to mediate NO-induced transcriptional up-regulation of sgII. A 
short DNA region with the sgII promoter and its CRE element was placed upstream of 
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Fig 4.6 sgII expression is mediated by c-Jun and is NO-inducible in SH-Sy5y cells.  (A) Microarray 
data comparing sgII expression in SH-Sy5y and TAM67 stable cells at two different time points 
following 2 mM SNP treatment. The numbers in the second and third columns refer to the absolute 
values of cy3 and cy5 fluorescence from which the fold reduction in sgII expression was calculated 
(column 4).  (B) SH-Sy5y cells and TAM67 cells were treated with 2 mM SNP or DETA-NO for the 





was transfected in SH-Sy5y cells, as did TPA acting as a positive control (Fig 4.7B). 
However, neither NO nor TPA activated luciferase activity when the same construct 
was transfected in TAM67 cells, and the basal luciferase activity was much lower in 
unstimulated TAM67 cells than in SH-Sy5y cells (Fig 4.7B), suggesting AP-1 is 
important for the expression of sgII in SH-Sy5y cells. To gain more direct evidence 
that CRE is important for sgII transcription, the CRE core box of the sgII promoter 
was mutated (Andrecht et al., 2002) and the reporter analysis was repeated. As shown 
in Fig 4.7C, basal, NO-inducible and TPA-inducible luciferase expression were all 
virtually abolished, indicating the critical importance of the CRE element in mediating 
sgII expression. 
Since the genes encoding other chromogranin family proteins (CgA, CgB and 
sgV) share some common cis-regulatory elements in their promoters (Taupenot et al., 
2003), I also examined the expression patterns of their mRNAs. Although, cgA, cgB 
and sgV each exhibited a basal level of expression in SH-Sy5y cells, none showed NO-
induced up-regulation like sgII (Fig. 4.8A); but strikingly, the expression of sgV was 
totally dependent on c-Jun/AP-1 (Fig. 4.8B). Altogether, these data show that sgII and 
sgV are regulated in large part by c-Jun/AP-1, and suggest that the single CRE element 
located upstream of the sgII gene is involved in c-Jun/AP-1-dependent basal 
expression and NO-stimulated induction of sgII.     
Consistent with the RT-PCR analyses, SgII protein was also considerably 
reduced in c-Jun-inhibited TAM67 cells compared to parental SH-Sy5y cells (Fig 
4.9A). Unlike the NO-inducible upregulation of sgII transcripts, the intracellular SgII 
protein remained at a constant level following NO treatment (Fig 4.9B, top panel). The 



























0 2 4 6 8 1010 2 4 6 810
Sy5y
TAM67











































Fig 4.7 sgII expression is mediated by c-Jun/AP-1 and requires a CRE motif in the sgII promoter. 
(A) SH-Sy5y cells were transfected with a CRE-luciferase reporter plasmid. 40 h after transfection, cells 
were treated with 2 mM SNP for the indicated times, harvested and luciferase activity was measured.  (B) 
SH-Sy5y cells (filled bars) or TAM67 cells (open bars) were transfected with a luciferase reporter 
plasmid bearing the human sgII promoter sequence. 40 h after transfection, cells were treated with 16 
nM TPA or 2 mM SNP for the indicated times and harvested. Luciferase activity was measured. (C) SH-
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Sy5y cells were transfected with a luciferase reporter plasmid bearing either the wild type sgII CRE 
(filled bars) or a mutated CRE (open bars). 40 hr after transfection, cells were treated with 16 nM TPA 
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Fig 4.8 Expression patterns of various chromogranin genes. (A) NO-inducible mRNA expression 
patterns of members of the chromogranin family in SH-Sy5y cells. SH-Sy5y cells were treated with 2 
mM SNP for the indicated times, total RNA was extracted and subjected to RT-PCR to detect the 
transcripts of cgA and cgB by agarose gel electrophoresis. (B) Basal and NO-inducible mRNA 
expression patterns of sgV in SH-Sy5y cells and TAM67 cells. SH-Sy5y cells and TAM67 cells were 
treated with 2 mM SNP for the indicated times, total RNA was extracted and subjected to RT-PCR to 



























Fig 4.9 Basal and NO-inducible SgII protein levels in SH-Sy5y and TAM67 cells. (A) Total proteins 
were extracted from SH-Sy5y cells, two independent clones of TAM67 stable cells (T13 and T18) and 
one sgII over-expressing SH-Sy5y cell (Sy-SgII) were separated in 8%SDS-PAGE followed by Western 
blot analysis to detect SgII. (B) Top panel, SH-Sy5y cells were treated with 2 mM SNP or DETA-NO 
for the indicated times, and total proteins were extracted. Bottom panel, SH-Sy5y cells were treated with 
2 mM SNP or DETA-NO for the indicated times. Total intracellular proteins as well as secreted proteins 
from the cell culture medium were extracted or collected, respectively. For both panels, the proteins 





due to a time-dependent, NO-inducible release of SgII into the culture medium. (Fig 
4.9B, bottom panel). 
 
4.4 SgII plays important roles in neuroprotection in NO-induced apoptosis as well 
as in NGF-induced neuronal differentiation 
Our laboratory has previously shown that c-Jun regulates NCAM140, and loss of 
NCAM140 in TAM67 cells partially sensitizes SH-Sy5y cells to apoptosis induced by 
NO and other oxidative stresses (Feng et al., 2002). To address whether SgII can also 
influence NO sensitivity, I stably reintroduced sgII cDNA (as a sgII-myc fusion) into 
TAM67 dominant-negative c-Jun cells, and obtained clones with varying degrees of 
SgII-Myc overexpression (Fig 4.10A, left panel) compared with the endogenous SgII 
expression levels (Fig 4.10A, right panel). Two independent SgII over-expressing 
clones both exhibited enhanced resistance to NO killing mediated by two different NO 
donors at various concentrations (Fig 4.10B), and caspase-3-like protease activity was 
correspondingly reduced in both clones (Fig 4.10D). Since caspase-3-like activity is 
required for NO-induced apoptosis, these data together suggest that SgII counteracts 
NO-mediated apoptosis of neuroblastoma cells. 
As mentioned above, sgV was expressed in SH-Sy5y but not TAM67 cells (Fig 
4.8B). However, in sharp contrast to sgII, stable expression of sgV in TAM67 cells 
failed to enhance resistance to NO donor-induced apoptosis (Fig 4.10C). This is 
evidence for a selective protective effect of SgII against NO toxicity compared with 
another member of the granin family. Our laboratory previously reported that c-
Jun/AP-1 is required for NGF-induced neuronal differentiation, and TAM67 cells fail 





















































































































Fig 4.10. Increased NO-resistance of TAM-67 stable cells over-expressing sgII. (A) Over-expression 
of sgII in TAM-67 stable cells. Right panel, Western blot showing over-expression of sgII in TAM67 
stable cells. The upper bands are SgII-c-Myc fusion proteins, and the lower bands represent endogenous 
c-Myc. Right panel, Western blot with SgII antibody detects the endogenous SgII in different cell lines. 
(B) SH-Sy5y cells, TAM-67 vector control cells and different sgII over-expressing TAM67 cell clones 
(T-S1, T-S2) were treated with different concentrations of SNP or SIN1 for 15 h, cells were harvested 
and the percentage of cell death was measured by LDH release assay. (C) TAM-67 cells and three 
different 7B2 overecpressing cells were treated with different concentrations of SNP for 15h, cells were 
harvested and percentage of cell death was measured by LDH release assay. (D) SH-Sy5y, T-S1 or T-S2, 
and TAM-67 vector control cells were treated with different concentrations of SNP for the indicated 
times, cells were harvested and caspase-3 activity was measured. 
 
 
The next question was whether the sgII/TAM67 stable cells would regain 
competence for NGF-induced neuronal differentiation following NGF treatment for 8 
days (aphidicolin was used together with NGF to enhance neuronal differentiation 
process by forcing cells exiting from cell cycle progression). Two independent clones 
of TAM67/sgII cells (T-S cells) as well as SH-Sy5y cells, but not TAM67 vector 
control cells, showed the classic neuronal differentiation morphology including neurite 
outgrowth, a network of interconnected neurons, and shrinkage of the cell bodies (Fig. 
4.11A). It is established that Bcl-2 is strongly up-regulated during neuronal 
differentiation of some neurons and neuroblastoma cells (Feng and Porter, 1999; 
Raguenez et al., 1999); and in certain cell types Bcl-2 regulates neurite outgrowth and 
differentiation (Eom et al., 2004; Hilton et al., 1997). NGF induced a steady up-
regulation of Bcl-2 in both sgII-over-expressing clones and SH-Sy5y cells, but not 
TAM67 stable cells that fail to differentiate (Fig 4.11B). Thus, SgII appears essential 
for NGF-induced neuronal differentiation by both morphological and biochemical 
criteria. In contrast, differentiation was not restored in TAM67 cells stably transformed 
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Fig 4.11 SgII over-expression restores neuronal differentiation in TAM67 cells. SH-Sy5y cells, 
TAM67 vector control cells and two independent clones of T-S stable cells (TAM67 cells over-
expressing sgII) were induced into neuronal differentiation by NGF and alphidicolin for up to 8 days. (A) 
Morphological changes described in the text are shown before (untr) and after differentiation (NGF 8d). 
(B) Cells were harvested after the indicated number of days, and total proteins in the lysates were 
separated in 12% or 15% SDS-PAGE gels. Bcl-2 protein was revealed by Western blotting.  Actin was 






To answer the question what are the physiological functions of SgII in SH-Sy5y 
cells, I used the siRNA approach in which only sgII expression is disrupted while the 
other potentially protective proteins are still synthesized. Six different oligonucleotides 
were chosen to stably knocked down sgII (details described in the “materials and 
methods”), and independent SH-Sy5y stable cell lines were generated (Fig 4.12A). 
Independent clones derived from two of the oligonucleotides which demonstrated a 60-
80% reduction in SgII protein (Fig. 4.12A) did not undergo NGF-mediated neuronal 
differentiation based on the morphological criteria (Fig 4.12B) and failure of Bcl-2 
upregulation 8 days after NGF addition (Fig 4.12C), which is in contrast to the vector 
control cells. Interestingly, the undifferentiated sgII knockdown cells underwent 
massive cell death (Fig. 4.12B), as did NGF-treated SgII-deficient TAM67 cells (Fig. 
4.11A). Moreover, reduction in SgII protein in two sgII knockdown clones sensitized 
SH-Sy5y cells to apoptosis induced by various concentrations of two different NO 
donors (Fig. 4.12D).  These results provide additional evidence that SgII is important 
in countering NO toxicity as well as promoting NGF-induced neuronal differentiation 
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Fig 4.12 Knock-down of sgII expression inhibits neuronal differentiation and sensitizes SH-Sy5y 
cells to NO-induced apoptosis. (A) SH-Sy5y cells were stably transfected with pSilencer–sgII 
constructs, hygromycin-resistant clones were isolated (551-16 and 619-N8), and total proteins were 
subjected to electrophoresis in 8% or 12% SDS-PAGE gels. SgII and actin levels were detected by 
Western blotting. (B) Vector control (pSilencer-VC) cells and two independent clones of sgII-siRNA 
(551-16 and 619-N8) were subjected to NGF-induced neuronal differentiation for 8 days as described in 
“materials and methods”. Morphological changes described in the text are shown before (untr) and after 
differentiation (NGF 8d). (C) Vector control (VC) and siRNA-expressing clones 551-16 and 619-N8 
cells were treated with NGF for the indicated number of days, harvested and total proteins in the lysates 
were separated in 12% or 15% SDS-PAGE. Bcl-2 protein was revealed by Western blotting.  Actin was 
the loading control. (D) Vector control (VC; open bars) cells and two different sgII-siRNA stable cell 
clones (551-16 and 619-N8) were treated with different concentrations of SNP (left panel) or SIN1 
(right panel) for 15 h, and the percentage of cell death was determined by LDH release assay. Values 




Proteins in the chromogranin family (collectively called granins) have a unique 
cellular localization in large dense core vesicles (LDCV’s) in neurons and 
neuroendocrine cells. Early studies focused on their properties with relevance to 
secretion like calcium binding, aggregation at the TGN (trans-Golgi network), and 
sorting for entry into the regulated pathway of secretion (Fischer-Colbrie et al., 1995; 
Taupenot et al., 2003). Three classical proteins in this family, CgA, CgB and SgII, 
were shown to be stored in the LDCVs and released together with other peptide 
hormones and neurotransmitters upon stimulation. Besides their functions as helper 
proteins in protein sorting at the TGN, they themselves are precursors of certain 
biologically functional peptides, being subject to proteolytic cleavage within the 
LDCVs (Natori and Huttner, 1994; Taupenot et al., 2003). In addition, CgA may have 
a role in pro-apoptotic processes (Ciesielski-Treska et al., 1998; Ciesielski-Treska et 
al., 2001; Kingham and Pocock, 2000; Taylor et al., 2002). Thus, granins fulfill 
neuronal cell functions and have potential roles in regulating neuronal cell viability.   
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 In this study, several novel findings were made. First, the expression and NO-
mediated up-regulation of sgII depends to a large extent on c-Jun/AP-1, and requires a 
CRE element located just upstream of the sgII promoter (Scammell et al., 2000). cgA, 
cgB and sgII all bear similar conserved CRE elements in their promoter regions 
(Taupenot et al., 2003), yet only sgII is expressed and up-regulated by NO in a c-
Jun/AP-1-dependent fashion. Because these conserved CRE elements dictate cell-type 
specific and inducible expression of granins, it is possible SH-Sy5y cells lack one or 
more additional factors needed for the CREs in the cgA and cgB promoters to respond 
to NO. Other novel findings in my study are that SgII (but not the family member SgV) 
mediates NGF-stimulated neuronal differentiation and protection from NO-induced 
apoptosis in a c-Jun/AP-1-dependent manner. These functions of SgII were rigorously 
demonstrated with two opposite but complementary approaches. In one, SgII synthesis 
was selectively restored in TAM67 cells that express very low levels of sgII. In another 
approach, sgII was specifically knocked down with siRNA in cells with normal c-
Jun/AP-1 function. Incomplete knockdown of sgII was sufficient to compromise 
neuronal differentiation and sensitize the cells to apoptosis, suggesting that even a 
modest reduction in the expression of SgII can affect cell differentiation and viability. 
Unlike SH-Sy5y cells, SgII-deficient TAM67 cells and sgII knockdown SH-Sy5y cells 
failed to differentiate and underwent massive cell death after NGF treatment, implying 
that SgII might also be neuroprotective during neuronal differentiation. From our 
previous work, NCAM140 is also essential for NGF-dependent neuronal 
differentiation and protection from NO-induced apoptosis of neuroblastoma cells 
(Feng et al., 2002). c-Jun/AP-1-inhibited TAM67 cells lack NCAM140 protein, which 
was restored by sgII expression (unpublished observations), implying that sgII over-
expression can up-regulate NCAM140 in a common survival/ differentiation pathway. 
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Overall my results indicate that SgII can mediate neuronal differentiation and 
protection from apoptosis even when other c-Jun/AP-1-regulated genes are repressed.    
How might SgII fulfill a dual function in neuroprotection and neuronal 
differentiation? SgII is the precursor of the peptide secretoneurin (SN), which is 
secreted and is consequently involved in many cellular processes including 
neurotransmitter release (Agneter et al., 1995; Saria et al., 1993), proliferation (Kahler 
et al., 1997a; Kahler et al., 1997b), and survival of cerebellar granule cells (Fujita et al., 
1999). Although a specific SN receptor has not been identified, there is evidence 
suggesting that SN might act via a classical G-protein-coupled receptor (Gasser et al., 
2003b; Kahler et al., 2002). Ligation of G-protein-coupled receptors is known to 
activate the MAP kinase cascade (Chakraborty, 2001) resulting in cell differentiation, 
survival or death (Schaeffer and Weber, 1999). sgII transcriptional activation was 
reported in neuronal cells challenged with different stresses (Chiang et al., 2001; Li et 
al., 2002). In one study, sgII upregulation was dependent on phosphatidyl-inositol-3-
kinase (PI3K) in response to oxidative stress (Li et al., 2002). Since PI3K is a well-
established survival signal transducer in neurons, it is conceivable that SgII is an 
important component of the PI3K-dependent survival pathway. Thus, SgII might 
mediate protection from NO directly or indirectly via secreted SN in an autocrine and 
paracrine fashion. Detection of secreted SgII is consistent with the former possibility. 
The presence of SgII in the growth medium might also explain why NO stimulated an 
increase in sgII mRNA but not intracellular SgII protein.     
Several reports proposed SgII as a marker of neuronal differentiation, based on 
observations that SgII is upregulated at the transcriptional and translational levels in 
several systems (Laslop and Tschernitz, 1992; Weiler et al., 1990b). In differentiated 
neuroblastoma cells, SgII was present in the Golgi and at the periphery of neurites and 
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in growth cones, but was virtually undetectable in undifferentiated cells (Giudici et al., 
1992). However, neither CgA nor CgB was found co-localized with SgII in the same 
organelles in differentiated cells. SgII always shows higher expression levels in 
different cells of the neuronal type or neural precursor cells (Hagn et al., 1986; Laslop 
and Tschernitz, 1992; Weiler et al., 1990a). Moreover, SN may contribute to neurite 
outgrowth of cultured neuronal cells (Gasser et al., 2003). Thus, NGF on the one hand 
might trigger differentiation-inducing signal transduction pathways leading to 
activation of transcription factors and their target genes including sgII. On the other 
hand, NGF could also promote the release of various components from LDCVs such as 
SN, resulting in the secondary activation of signal transduction pathways required for 
















CHAPTER 5   How opposite functions of AP-1 factors are 
achieved in a single cell line  
 
In chapter 3, I showed that phospho-c-Jun played a pro-apoptotic role in NO-
induced apoptosis in SH-Sy5y cells based on the discovery that JunAA/S63A stable 
cells are more resistant to NO. In chapter 4, an anti-apoptotic function of c-Jun/AP-1 in 
response to the same stimuli is revealed based on the observation that TAM67 stable 
cells are more sensitive to NO. It is important to explain the opposing effects of the 
dominant-negative c-Jun (TAM-67) and S63A/ JunAA in an attempt to understand the 
role(s) of c-Jun/AP-1 in NO-induced apoptosis. 
 
5.1 Structural differences between TAM67 and JunAA/S63A determines their 
functional discrepancy 
Firstly, it is necessary to examine the structural difference between the two 
dominant-negative mutants of c-Jun (TAM67 and JunAA/S63A). In the TAM67 
mutant, most of the transactivation domain of c-Jun is deleted, while in the 
JunAA/S63A mutant, the transactivation domain of c-Jun is intact except for one or 
two point mutations (both Ser-63 and Ser-73 are mutated to Ala or only Ser63 is 
mutated to Ala) as shown in Fig 5.1. From earlier studies, phosphorylation of Ser-63 
and Ser-73 is essential for full activation of c-Jun with various stimuli (Behrens et al., 
1999; Smeal et al., 1991). However, phosphorylation of these two residues is 
dispensable for basal c-Jun activity. Support for a phosphorylation-independent 
function of c-Jun comes from several other directions. For example, mutant mice in 
which the c-Jun locus is replaced by JunAA are healthy and fertile although they are 
obviously smaller in size than their wild type counterparts (Behrens et al., 1999), in 
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contrast to the embryonic lethality of Jun-/- mice (Johnson et al., 1993), suggesting 
JunAA retains basal c-Jun activity despite the fact that its full activity is compromised.  
In addition, JunAA itself can regulate transcription by acting as a suppressor and 
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Fig 5.1 Comparison of structures of wild type c-Jun, TAM67 and JunAA/S63A 
 
 
Thus, the structural difference between TAM67 and JunAA might explain the 
different phenotypes of the respective dominant-negative cells. Over-expressed 
TAM67 could potentially inhibit general AP-1 mediated transcription (Brown et al., 
1994; Thompson et al., 2002) since c-Jun is an essential component of AP-1 dimers. 
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On the contrary, JunAA expression would only quench phospho-c-Jun mediated events 
which result from external stimuli, leaving the basal c-Jun-dependent events unaffected. 
This is proven by reporter analysis comparing the basal AP-1 activity in wild type SH-
Sy5y cells, TAM67 stable cells and S63A stable cells. As shown in Fig 5.2, TAM67 
over-expression resulted in dramatic inhibition of AP-1-mediated transcription in SH-
Sy5y cells, while S63A expression slightly enhanced AP-1-mediated transcription, 
probably due to a slight excess of S63A in the cells (Fig 3.4A). However, over-
expression of JunAA/S63A inhibited NO-induced c-Jun activity which is dependent on 
the phosphorylation of c-Jun on Ser-63 (Fig 3.6A), suggesting the non-phosphorylated 
mutant of c-Jun (JunAA/S63A) is able to counteract the deleterious effects arising 
from c-Jun phosphorylation.  
















Fig 5.2 Comparison of AP-1 activity in wild type SH-Sy5y cells, TAM67 stable cells and 
JunAA/S63A stable cells.  The TRE-reporter plasmid was cotransfected with the RPL-TK plasmid into 
SH-Sy5y, TAM67, S63A and JunAA stable cells. 40 h later, the cells were harvested. Firefly luciferase 
activity was measured, and Renilla luciferase activity was measured as an internal control.  
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It is concluded that TAM67 interferes with most c-Jun/AP-1 dependent 
transcription events irrespective of the c-Jun phosphroylation, while JunAA/S63A 
specifically inhibits phospho-c-Jun mediated events.  
 
5.2 Molecular mechanisms responsible for the apparent differences between 
TAM67 and JunAA/S63A stable cells 
Since basal AP-1 activity in TAM67 and JunAA/S63A stable cells is different, it 
is likely that this accounts for the huge difference in their sensitivity to NO.  
It has been previously shown by my laboratory that the synthesis of NCAM140, a 
neuroprotective protein, is AP-1 dependent in SH-Sy5y cells (Feng et al., 2002). 
NCAM (neural cell adhesion molecule) belongs to the immunoglobulin superfamily, 
and three major isoforms may be generated from a single gene by alternative splicing 
(Doherty and Walsh, 1992; Tacke and Goridis, 1991). Using primers specific for exon 
18 of NCAM, a unique exon present in NCAM180 transcripts but not in NCAM140 
transcripts (Fig 5.3A), it was found that NCAM180 is only expressed in TAM67 cells 
(Fig 5.3C). Consistently, different patterns of NCAM140 and NCAM180 synthesis in 
vector control and TAM67 stable cells were also observed (Fig 5.3B). NCAM140 
synthesis is not dependent on c-Jun phosphorylation since a basal level of NCAM140 
is maintained without NO treatment, which decreases with NO stimulation (Fig 5.4A).  
Furthermore, NCAM140 counteracts NO toxicity. When a cDNA encoding NCAM140 
was stably transfected into TAM67 cells (NCAM140 negative), cells showed a marked 
resistance to NO-induced apoptosis compared with TAM67 cells (Feng et al., 
2002)(Fig 5.4B).  
However, in JunAA and S63A stable cells, in which basal AP-1 activity is still 
normal, both the transcription of NCAM140 and the synthesis of NCAM140 are 
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unaffected (Fig 5.5 A, B), suggesting the NCAM140-mediated survival pathway is 

















Fig 5.3 NCAM140 synthesis is AP-1 dependent in SH-Sy5y cells. (A) Comparison of mRNA 
structure of NCAM140 and NCAM180. (B) Total proteins from vector control and TAM67 stable cells 
were extracted and subjected to 6% SDS-PAGE followed by western blot analysis using an antibody 
against NCAM. (C) Total RNA was extracted from vector control and TAM67 stable cells. RT-PCR 
detected NCAM180 synthesis (using a primer specific for exon 18) and NCAM140 synthesis. Actin was 



















Fig 5.4 NCAM140 protects SH-Sy5y cells from NO-induced apoptosis. (A) NCAM140 synthesis is 
not dependent on NO-induced phosphorylation of c-Jun. SH-Sy5y cells were treated with 2 mM SNP for 
the indicated times and total proteins were extracted and subjected to 6% SDS-PAGE followed by 
westwen blot analysis using an NCAM antibody. (B) TAM67 stable cells, TAM67 cells overexpressing 
NCAM140 and their vector control cells were treated with 2mM SNP for 15 h, and the percentage of 






































Fig 5.5 NCAM140 expression is intact in JunAA/S63A stable cells. (A) Total proteins from SH-Sy5y, 
TAM67, S63A as well as NCAM140 over-expressing TAM67 cells (T-NCAM) were prepared and 
subjected 6% SDS-PAGE followed by western blot analysis using an antibody against NCAM. (B) Total 
RNA was extracted from SH-Sy5y, TAM67, S63A and JunAA stable cells. RT-PCR was done to detect 
NCAM180 transcripts by using a primer specific for exon 18 of the NCAM gene (a unique exon present 
in NCAM180 transcripts). 
 
 
In chapter 4, I discussed the neuroprotective gene sgII whose expression is AP-1 
dependent, because basal and inducible sgII transcription and basal SgII translation 
were severely compromised in TAM67 stable cells. Since JunAA/S63A over-
expression did not affect the basal activity of AP-1 in SH-Sy5y cells, I also checked 
the expression of sgII in these cells. In sharp contrast to TAM67 cells, sgII 
transcription and translation in JunAA/S63A cells was similar to wild type SH-Sy5y 
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cell levels (Fig 5.6A, B), indicating a SgII-mediated survival pathway is also intact in 



































Fig 5.6 SgII expression is intact in JunAA/S63A stable cells. (A) Total proteins from SH-Sy5y,  sgII- 
overexpressing SH-Sy5y cells (Sy-S7), S63A, JunAA and TAM67 stable cells were prepared and 
subjected 8% SDS-PAGE followed by western blot analysis using an antibody against SgII. (B) Total 
RNA was extracted from SH-Sy5y, S63A, JunAA and TAM67 stable cells. RT-PCR was done using 






A speculative model is presented in Fig. 5.7 that can help to understand NO-
activated transcription in SH-Sy5y cells and how the two different dominant-negative 
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forms of c-Jun might affect transcription. The TAM-67 dominant-negative protein is 
able to efficiently inhibit general AP-1-mediated transcription including the expression 
of certain neuroprotective genes (NCAM140 and sgII); therefore, the cells become 
more sensitive to NO. The synthesis of NCAM140 and SgII does not presumably 
require Ser-63 phosphorylation of c-Jun, because it occurs in the absence of NO 
stimulation, which is essential to activate the JNK-phospho-c-Jun pathway. In contrast 
to TAM-67 cells, NCAM140 and SgII protein are still synthesized at normal levels in 
NO-resistant S63A and JunAA cells. This indicates the constitutive c-Jun/AP-1-
dependent NCAM140 / SgII survival pathway(s) are intact in these cells.  In other 
words, the S63A and JunAA (and related constructs) block the pro-apoptotic JNK-c-
Jun pathway without affecting the synthesis of neuroprotective NCAM-140 and SgII, 
so the cells are resistant to apoptosis compared to SH-Sy5y cells and TAM-67 cells. 
DN-jnk could achieve similar effects through inhibition of JNK and thus block c-Jun 
phosphorylation. 
Consistent with the studies shown in this thesis, it was reported that c-Jun can 
protect undifferentiated rat PC12 neuronal cells from apoptosis independently of c-Jun 
phosphorylation, but in the fully differentiated cells JNK signaling can induce 
apoptosis and c-Jun mediates this response (Leppa et al., 2001). However, NO was not 
one of the apoptosis paradigms used. Based on the current study, it is evident that c-
Jun/AP-1 can fulfill opposite functions in a single undifferentiated neuroblastoma cell, 
which I speculate occurs in the following context. A constitutive or basal activity of c-
Jun/AP-1 factor(s) (independent of c-Jun phosphorylation on Ser-63) is able to 
counteract relatively low levels of NO - in part through the constant expression of 
neuroprotective NCAM140 and SgII. In contrast, a toxic concentration of NO will lead 
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to c-Jun phosphorylation on Ser-63 by JNK that triggers apoptosis via yet discovered 

























Fig 5.7 Speculative model of how different dominant-negative forms of c-Jun (TAM-67 and S63A/ 
JunAA) have opposite effects on the sensitivity of SH-Sy5y cells to NO. (A) TAM-67 over-
expression in SH-Sy5y cells leads to a general suppression of c-Jun/AP-1-dependent transcription, 
including protective genes encoding NCAM140 and SgII, regardless of phosphorylation of c-Jun on Ser-
63 and Ser-73. Therefore, TAM-67 cells are sensitized to apoptosis. (B) S63A and JunAA only block 
pro-apoptotic phospho-c-Jun dependent events such as caspase-3 activation, whereas the phospho c-Jun-
independent neuroprotective NCAM140 is still synthesized in the S63A stable cells. Therefore, S63A 
and JunAA cells are more resistant to apoptosis than SH-Sy5y cells.  DN-jnk (-1 or -2) inhibits the 
activity of JNK, leading to the failure to phosphorylate c-Jun, which therefore has the same effect as 




CHAPTER 6     Implications and Future Prospects 
 
Nitric oxide (NO) is an important molecule mediating various physiological as 
well as pathophysiological processes. NO has received more attention in recent years, 
since it is functionally involved in the pathology of acute or chronic neurological 
disorders (Lipton, 1999). Furthermore, due to the complex chemical reactions of NO, it 
is potentially implicated in the process of aging. It is relevant to understand the 
mechanisms whereby NO exerts its notorious effects on cells and what defensive 
responses the cells can activate to counteract NO toxicity. AP-1 was among the first 
identified mammalian transcription factors, but the physiological functions are still far 
from elucidated. The complexity of AP-1 functions is believed to arise from the 
different compositions of AP-1 dimers and different sets of target genes activated by 
AP-1 in cell-, development stage- or stimulus-specific manners. Identification of these 
targets genes will be helpful in understanding the diverse AP-1 functions in different 
situations (Karin et al., 1997). In the current study, I investigated two distinct but 
interconnected events elicited by AP-1 in response to NO: a pro-apoptotic event 
activated by AP-1 due to c-Jun phosphorylation and an anti-apoptotic pathway 
activated by AP-1 due to expression of two neuroprotective genes.  
It is established that phosphorylation of Ser-63 and Ser-73 on c-Jun usually 
enhances its transcriptional activity. However, it was not previously addressed whether 
single phosphorylation of one or the other of these two residues might occur under 
some circumstances and if so, what might be the the physiological relevance? 
In the current study, I found Ser-63 of c-Jun to be heavily phosphorylated upon 
NO stimulation in two neuroblastoma cells (SH-Sy5y and SHEP cells) while the Ser-
73 phosphorylation is marginally detectable. Further studies proved that this 
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phosphrylation is mediated by JNK and not p38. What is the mechanism underlying 
the single phosphorylation of c-Jun? MAPKs are highly specific in their choice of 
substrates. In the case of JNK and c-Jun, efficient phosphorylation of c-Jun by JNKs 
requires a docking site located between amino acids 30 and 60 of c-Jun, a proline 
residue following the serine residue to be phosphorylated as well as specific residues 
flanking the phosphoacceptor site (Karin, 1995). The first possibility is that c-Jun is 
defective in the structure mentioned above in the two cell lines I used. Strong 
phosphorylation on both Ser-63 and Ser-73 of c-Jun upon UV irradiation argues that c-
Jun is, however, intact in this region. Another possibility is that NO activates a specific 
JNK isoform which has higher affinity for Ser-63 than Ser-73. JNK2 has higher 
affinity to c-Jun than JNK1 because of a small region near its catalytic pocket 
(Kallunki et al., 1994). It is reasonable to speculate that unique or particular structural 
features of different JNK isoforms might determine their preference for their substrates. 
Further experiments can be done to study which JNK isoform(s) have been activated 
by NO and further analyze their contributions to c-Jun phosphorylation. Cells from 
mice deficient for particular JNK isoforms might also be useful to address this question. 
A third possibility is that NO might activate specific phosphatases which specifically 
recognize and rapidly dephosphorylate phosphor-Ser-73. Known phosphatase 
inhibitors might be useful in testing this hypothesis. A fourth possibility is that putative 
NO-mediated chemical modification (e.g. nitrosation) of c-Jun could preferentially 
block Ser-73 phosphorylation.  
I have shown predominant Ser-63 phosphorylation of c-Jun in response to NO is 
functionally important; it enhances c-Jun as well as AP-1 transcriptional activity in 
SH-Sy5y cells; it also results in apoptosis in both SH-Sy5y and SHEP cells. What is 
the mechanism of phospho-c-Jun in mediating apoptosis? Besides contributing to 
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caspase-3 activation (most probably indirectly), phospho-c-Jun (S63) might induce a 
different spectrum of target genes compared with the un-phosphorylated c-Jun or dual-
phosphorylated c-Jun, resulting in a shift to an overwhelming expression of death 
genes. A recent publication reports the sole phosphorylation of c-Jun on Ser-73 in 
cultured sympathetic neurons deprived of glial cell line–derived neurotrophic factor 
(GDNF) (Yu et al., 2003). However, the biological significance of c-Jun 
phosphorylation on Ser-73 in GDNF withdrawal-induced cell death is not clear. 
Importantly, another publication reports that absence of c-Jun phosphorylation on Ser-
63 in response to an oxidative stress-inducer (3-NPA) might play a role in slowing the 
aging process in Snell Dwarf mice (Madsen et al., 2004). It is intriguing but remains to 
be determined whether slower aging is connected to lower levels of oxidative stress 
and apoptosis resulting from lack of Ser-63 phosphorylation. These observations 
provide additional evidence that under certain circumstances, phosphorylation of c-Jun 
on either Ser-63 or Ser-73 can occur and may have functional relevance. Comparing 
the gene expression profiles when c-Jun is un-phosphorylated, dual-phosphorylated 
and S63/S73-phosphorylated will be helpful in understanding the molecular 
mechanisms underlying these different events. 
The role of AP-1 in apoptosis is complex; its activation can be proapoptotic, 
antiapoptotic or irrelevant to apoptosis. The precise function of AP-1 and actual cell 
fate in response to a specific stimulus is dependent on the cellular context in which 
AP-1 is activated, including co-activation of other signaling molecules which might 
directly or indirectly affect AP-1 activity, activation of the dimerization components of 
AP-1 which will determine the spectrum of AP-1 target genes (Chinenov and Kerppola, 
2001). In the current studies, I notably found that c-Jun/AP-1 can fulfill both anti- and 
pro-apoptotic functions in a single cell line in response to a single stimulus. Consistent 
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with these studies, it was reported that c-Jun can protect undifferentiated rat PC12 
neuronal cells from apoptosis independently of c-Jun phosphorylation, but in the fully 
differentiated cells JNK signaling can induce apoptosis and phosphorylated c-Jun 
mediates this response (Leppa et al., 2001). The former event does not seem to depend 
on c-Jun transcriptional activity while the latter one does. Based on my studies 
presented here, both pro- and anti-proapoptotic activity of c-Jun/AP-1 are apparently 
mediated by its transcription activity, which might occur in the following context: a 
constitutive or basal activity of c-Jun/AP-1 factor(s) (independent of c-Jun 
phosphorylation on Ser-63) is able to counteract relatively low levels of NO - in part 
through the constant expression of neuroprotective NCAM140 and SgII. In contrast, a 
toxic concentration of NO will lead to c-Jun phosphorylation on Ser-63 by JNK that 
triggers apoptosis via yet discovered c-Jun targets. It is also possible that other 
transcription factors activated by NO can affect AP-1 activity and cell viability. My 
colleagues have demonstrated that activation of the transcription factor Nrf2 
counteracts NO toxicity (Dhakshinamoorthy and Porter, 2004). According to my 
preliminary unpublished results, Nrf2 is able to suppress JNK-c-Jun signaling. Thus, in 
Nrf2 over-expressing SH-Sy5y cells, death is prevented partially due to the 
postponement of the NO-induced phosphorylation of c-Jun. Conversely, in SH-Sy5y 
cells over-expressing DN-Nrf2 or in Nrf2 knockdown cells, the increase in NO-
induced c-Jun transcriptional activity starts at an earlier time point, suggesting an 
earlier activation of JNK-c-Jun signaling, and consequently increased apoptosis. It will 
be important to investigate how Nrf2 delays c-Jun phosphorylation. 
It is also important to note that the non-phosphorylated mutant of c-Jun 
(JunAA/S63A) efficiently prevents NO-induced cell death while leaving the basal c-
Jun/AP-1 dependent transcription (e.g. NCAM140, SgII) unaffected. Since 
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phosphorylation of c-Jun mostly occurs when cells are challenged with stress which 
might lead to cell death, inhibition of c-Jun Ser-63/Ser-73 phosphorylation could be a 
potential therapeutic approach when prevention of cell death is required, such as in 
acute or chronic neurological disorders.  
Identification of pathway-specific AP-1 target gene(s) is essential in 
understanding the diverse functions of AP-1 achieved under different circumstances. 
Among the chromogranin family genes, sgII is uniquely responsive to NO in SH-Sy5y 
cells. Furthermore, basal expression of sgII also relies heavily on AP-1 factors through 
the conserved CRE motif within its promoter region. These observations help to 
explain the protective role of AP-1 in countering NO toxicity in SH-Sy5y cells. 
Although it is unclear how the dual functions of SgII (neuroprotection and neuronal 
differentiation) are achieved, there are some clues that the biologically functional 
peptides derived from SgII cleavage might account for it (Taupenot et al., 2003). SN 
(secretoneurin) is the best characterized peptide derived from SgII, involved in various 
biological processes including stimulation of proliferation and promotion of neurite 
outgrowth in certain cell types (Taupenot et al., 2003; Wiedermann, 2000). A simple 
way to test whether SN is responsible for SgII-mediated survival and neuronal 
differentiation is to block SN function by applying either anti-SN serum or pertussis 
toxin (PTX) (Gasser et al., 2003) on SH-Sy5y cells. If the cells were sensitized to NO-
induced cell death or unable to undergo NGF-induced neuronal differentiation, SgII 
might function through SN. Involvement of other SgII-derived peptides in fulfilling 
SgII functions cannot be excluded. SH-Sy5y cells either over-expressing non-cleavable 
SgII or bearing non-functional PCs (endoproteinases responsible for SgII cleavage) 
(Fischer-Colbrie et al., 1995) will be helpful to answer whether SgII cleavage is 
important for its functions. 
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Another intriguing finding is the re-synthesis of NCAM140 in TAM67 cells 
over-expressing SgII (my unpublished observations). This observation places the 
NCAM140 and SgII in a possibly common regulatory pathway. NCAM140 is a trans-
membrane protein (Cunningham et al., 1987), usually targeted to the plasma 
membrane through the constitutive secretory pathway after synthesis; SgII is a 
classical protein located in the regulated secretory pathway although there is evidence 
SgII may localize in the constitutive secretory pathway as well in certain cell types 
(Fischer-Colbrie et al., 1995). Three NCAM isoforms (120, 140 and 180 KDa 
respectively) arise from post-transcriptional splicing (Cunningham et al., 1987; Tacke 
and Goridis, 1991). It is not clear how SgII could affect the splicing process, an event 
occurring in the nucleus. However, NCAM140 synthesis is intact in SgII knockdown 
cells (my unpublished observations), suggesting SgII is not essential for NCAM 
splicing. Conversely, NCAM140 synthesis is completely compromised in TAM67 
stable cells (Feng et al., 2002), indicating an essential role of AP-1 in NCAM splicing. 
Based on the experimental results, SgII seems required but not sufficient for 
NCAM140 synthesis in SH-Sy5y cells, which might happen in the following contexts: 
redundant pathways for NCAM140 synthesis exists in SH-Sy5y cells: one is dependent 
on AP-1 activity (probably through regulating the production or activity of splicing 
factors) and it is a predominant pathway (Feng et al., 2002). So long as normal AP-1 
activity is present in the cells, NCAM140 is synthesized; another pathway is dependent 
on SgII and it is a minor pathway, functioning only when AP-1 activity is severely 
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